$ste 2024 Q2 10-K

Concept	2024 Q2	2024 Q1	2024
Revenue	$1.280B	$1.419B	$5.139B
YoY Change	-0.39%	2.49%	3.65%
Cost Of Revenue	$707.1M	$836.5M	$2.921B
YoY Change	-0.56%	4.98%	4.37%
Gross Profit	$572.4M	$582.9M	$2.218B
YoY Change	-0.18%	-0.88%	2.71%
Gross Profit Margin	44.74%	41.07%	43.17%
Selling, General & Admin	$335.6M	$309.1M	$1.252B
YoY Change	-6.53%	-7.99%	-3.58%
% of Gross Profit	58.63%	53.02%	56.46%
Research & Development	$25.57M	$27.46M	$103.7M
YoY Change	0.28%	4.07%	2.07%
% of Gross Profit	4.47%	4.71%	4.67%
Depreciation & Amortization	$112.7M	$134.4M	$565.2M
YoY Change	-18.29%	-5.46%	2.23%
% of Gross Profit	19.69%	23.06%	25.48%
Operating Expenses	$386.9M	$336.5M	$1.356B
YoY Change	0.61%	-7.11%	-3.17%
Operating Profit	$185.5M	$246.4M	$862.2M
YoY Change	-1.78%	9.13%	13.56%
Interest Expense	$30.38M	-$29.77M	$144.4M
YoY Change	-6.11%	-1.69%	33.67%
% of Operating Profit	16.38%	-12.08%	16.74%
Other Income/Expense, Net	-$10.27M	-$29.76M	-$133.3M
YoY Change	-66.83%	-1.72%	20.27%
Pretax Income	$175.3M	$190.6M	$702.8M
YoY Change	10.98%	-2.33%	346.66%
Income Tax	$35.31M	$37.28M	$149.5M
% Of Pretax Income	20.15%	19.56%	21.28%
Net Earnings	$145.4M	-$1.377M	$378.2M
YoY Change	17.68%	-100.74%	253.4%
Net Earnings / Revenue	11.36%	-0.1%	7.36%
Basic Earnings Per Share	$1.47	-$0.01	$3.83
Diluted Earnings Per Share	$1.46	-$0.01	$3.80
COMMON SHARES
Basic Shares Outstanding	98.90M shares	98.81M shares	98.79M shares
Diluted Shares Outstanding	99.38M shares		99.36M shares

Concept	2024 Q2	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$198.3M	$207.0M	$207.0M
YoY Change	-4.93%	-0.64%	-0.64%
Cash & Equivalents	$198.3M	$207.0M	$207.0M
Short-Term Investments
Other Short-Term Assets	$151.0M	$985.7M	$985.7M
YoY Change	-9.08%	449.8%	449.8%
Inventory	$698.6M	$674.5M	$674.5M
Prepaid Expenses
Receivables	$892.6M	$1.008B	$1.008B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.940B	$2.876B	$2.876B
YoY Change	-4.47%	42.96%	42.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.834B	$1.938B	$1.938B
YoY Change	-4.54%	2.17%	2.17%
Goodwill	$4.057B	$4.071B
YoY Change	4.38%	4.94%
Intangibles	$2.049B	$2.119B
YoY Change	-28.48%	-28.3%
Long-Term Investments
YoY Change
Other Assets	$63.13M	$67.92M	$67.92M
YoY Change	-21.13%	-13.08%	-13.08%
Total Long-Term Assets	$8.168B	$8.196B	$8.196B
YoY Change	-6.68%	-6.97%	-6.97%
TOTAL ASSETS
Total Short-Term Assets	$1.940B	$2.876B	$2.876B
Total Long-Term Assets	$8.168B	$8.196B	$8.196B
Total Assets	$10.11B	$11.07B	$11.07B
YoY Change	-6.27%	2.31%	2.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$231.7M	$251.7M	$251.7M
YoY Change	-11.11%	-9.98%	-9.98%
Accrued Expenses	$286.6M	$319.7M	$362.2M
YoY Change	-13.88%	0.61%	21.35%
Deferred Revenue
YoY Change
Short-Term Debt	$80.00M	$85.94M	$0.00
YoY Change	26.11%	43.23%
Long-Term Debt Due	$80.00M	$85.94M	$85.94M
YoY Change	26.11%	43.23%	43.23%
Total Short-Term Liabilities	$834.4M	$939.3M	$939.3M
YoY Change	-5.93%	8.98%	8.98%
LONG-TERM LIABILITIES
Long-Term Debt	$2.236B	$3.120B	$3.120B
YoY Change	-21.84%	3.36%	3.36%
Other Long-Term Liabilities	$72.37M	$697.1M	$697.1M
YoY Change	-91.58%	-18.39%	-18.39%
Total Long-Term Liabilities	$2.308B	$3.817B	$3.817B
YoY Change	-37.94%	-1.44%	-1.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$834.4M	$939.3M	$939.3M
Total Long-Term Liabilities	$2.308B	$3.817B	$3.817B
Total Liabilities	$3.738B	$4.756B	$4.756B
YoY Change	-18.84%	0.46%	0.46%
SHAREHOLDERS EQUITY
Retained Earnings	$2.178B	$2.088B
YoY Change	9.95%	9.21%
Common Stock	$4.500B	$4.543B
YoY Change	0.03%	1.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.355B	$6.315B	$6.315B
YoY Change
Total Liabilities & Shareholders Equity	$10.11B	$11.07B	$11.07B
YoY Change	-6.27%	2.31%	2.31%

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	$145.4M	-$1.377M	$378.2M
YoY Change	17.68%	-100.74%	253.4%
Depreciation, Depletion And Amortization	$112.7M	$134.4M	$565.2M
YoY Change	-18.29%	-5.46%	2.23%
Cash From Operating Activities	$303.7M	$254.8M	$973.3M
YoY Change	8.04%	18.08%	28.58%
INVESTING ACTIVITIES
Capital Expenditures	$108.1M	$91.50M	$360.3M
YoY Change	62.28%	28.06%	-0.45%
Acquisitions	$13.66M		$546.3M
YoY Change			1183.13%
Other Investing Activities	$795.9M	-$4.110M	-$527.0M
YoY Change	15918140.0%	-32.94%	2367.28%
Cash From Investing Activities	$687.8M	-$95.61M	-$887.4M
YoY Change	-1132.84%	23.24%	131.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$1.293M
YoY Change			-99.58%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$998.9M	-143.8M	-85.19M
YoY Change	367.58%	-25.1%	-82.92%
NET CHANGE
Cash From Operating Activities	$303.7M	254.8M	973.3M
Cash From Investing Activities	$687.8M	-95.61M	-887.4M
Cash From Financing Activities	-$998.9M	-143.8M	-85.19M
Net Change In Cash	-$8.692M	15.43M	727.0K
YoY Change	-1070.09%	-128.72%	-100.58%
FREE CASH FLOW
Cash From Operating Activities	$303.7M	$254.8M	$973.3M
Capital Expenditures	$108.1M	$91.50M	$360.3M
Free Cash Flow	$195.7M	$163.3M	$612.9M
YoY Change	-8.8%	13.13%	55.19%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	98900010	shares
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.84
CY2024	us-gaap	Restructuring Costs RestructuringCosts	26045000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1189625000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	477815000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2879000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-111012000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	380079000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	105813000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	242870000	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1840000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1018000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	107030000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	243888000	usd
CY2024	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-7211000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-109638000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-7947000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-110902000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-148565000	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	370292000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3872000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	95323000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	57660000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22193000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-15117000	usd
CY2024	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-736000	usd
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001757898
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	98900010	shares
CY2023Q3	dei	Entity Public Float EntityPublicFloat	21614000000	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	14250000	usd
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-38848
CY2024	dei	Entity Registrant Name EntityRegistrantName	STERIS plc
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L2
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1455064
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	70 Sir John Rogerson's Quay,
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin 2,
CY2024	dei	Entity Address Country EntityAddressCountry	IE
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	D02 R296
CY2024	dei	Country Region CountryRegion	353
CY2024	dei	City Area Code CityAreaCode	1
CY2024	dei	Local Phone Number LocalPhoneNumber	232 2000
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	false
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	21614000000	usd
CY2024	dei	Auditor Firm AuditorFirmId	42
CY2024	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2024	dei	Auditor Location AuditorLocation	Cleveland, Ohio
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	207020000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208357000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	22984000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	19284000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1008315000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	864988000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	674535000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	604410000	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	174349000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	176107000	usd
CY2024Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	804904000	usd
CY2023Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	157580000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	2869123000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	2011442000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1765180000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1632775000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	173201000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	166553000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4070712000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	3879219000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2119282000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2076699000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	66199000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	77892000	usd
CY2024Q1	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	977259000	usd
CY2024Q1	us-gaap	Assets Assets	11063697000	usd
CY2023Q1	us-gaap	Assets Assets	10821839000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	251723000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	264165000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	13640000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	40477000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	164831000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	118463000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31239000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	30065000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	85938000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	60000000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	319744000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	298032000	usd
CY2024Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	64012000	usd
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	50642000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	931127000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	861844000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3120162000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3018655000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	479688000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	617538000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	145828000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	139557000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	71546000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	76137000	usd
CY2024Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	usd
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	20936000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	4748351000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	4734667000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	98883000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	98883000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	98629000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	98629000	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	4543176000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	4486375000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2087645000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1911533000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-328657000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-320710000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6302164000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6077198000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	13182000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	9974000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6315346000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6087172000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11063697000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10821839000	usd
CY2024	us-gaap	Revenues Revenues	5138701000	usd
CY2023	us-gaap	Revenues Revenues	4536266000	usd
CY2022	us-gaap	Revenues Revenues	4223403000	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2920541000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2555540000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2340396000	usd
CY2022	us-gaap	Gross Profit GrossProfit	1883007000	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	1382042000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	836118000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	791101000	usd
CY2024	us-gaap	Interest Expense InterestExpense	144351000	usd
CY2023	us-gaap	Interest Expense InterestExpense	107956000	usd
CY2022	us-gaap	Interest Expense InterestExpense	89490000	usd
CY2024	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	0	usd
CY2023	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	0	usd
CY2022	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	27806000	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11043000	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-133308000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-110835000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	702810000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	680266000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	366803000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	149530000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	124069000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82344000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	553280000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	556197000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	284459000	usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-173201000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-450384000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-41589000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1217000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	378239000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	5.58
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	5.59
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.93
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-1.75
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-4.52
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.43
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.83
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.07
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.50
CY2024	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	5.55
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	5.56
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.90
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-1.74
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-4.49
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.42
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.81
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.07
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.48
CY2024	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.03
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.84
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.69
CY2024	us-gaap	Profit Loss ProfitLoss	380079000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	105813000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	242870000	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1840000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1217000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1018000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	378239000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	107030000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	243888000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-155000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	521000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	507000	usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-1264000	usd
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	6795000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-155360000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	242870000	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	565244000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	552897000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	553104000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-131412000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-185913000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-106620000	usd
CY2022	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	usd
CY2024	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1500000	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	56535000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	38951000	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-24997000	usd
CY2024	ste	Loss On Classification As Held For Sale LossOnClassificationAsHeldForSale	206444000	usd
CY2023	ste	Loss On Classification As Held For Sale LossOnClassificationAsHeldForSale	0	usd
CY2022	ste	Loss On Classification As Held For Sale LossOnClassificationAsHeldForSale	0	usd
CY2024	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-873000	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	67000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	874000	usd
CY2024	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	546000	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2024	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	0	usd
CY2023	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	0	usd
CY2022	ste	Fair Value Adjustment Related To Convertible Debt Liability FairValueAdjustmentRelatedToConvertibleDebtLiability	27806000	usd
CY2024	ste	Amortization Of Inventory Fair Value Adjustments AmortizationOfInventoryFairValueAdjustments	4822000	usd
CY2023	ste	Amortization Of Inventory Fair Value Adjustments AmortizationOfInventoryFairValueAdjustments	7363000	usd
CY2022	ste	Amortization Of Inventory Fair Value Adjustments AmortizationOfInventoryFairValueAdjustments	66663000	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	490565000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-12316000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	24832000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	21639000	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	128069000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	133304000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	51969000	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	37450000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	123921000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	102922000	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1552000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	24086000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7126000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-18962000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	53342000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	14887000	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	39955000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-22054000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-16398000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	973274000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	756947000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	684811000	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	360326000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	361969000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	287563000	usd
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7381000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	14587000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1741000	usd
CY2024	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	9458000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	6624000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	169712000	usd
CY2024	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	3882000	usd
CY2023	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2024	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	546256000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	42572000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	550449000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-887361000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-383330000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-666559000	usd
CY2024	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	1350000000	usd
CY2024	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	650000000	usd
CY2024	ste	Repayments Of Term Loans RepaymentsOfTermLoans	60000000	usd
CY2023	ste	Repayments Of Term Loans RepaymentsOfTermLoans	156875000	usd
CY2022	ste	Repayments Of Term Loans RepaymentsOfTermLoans	345000000	usd
CY2024	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	0	usd
CY2023	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	91000000	usd
CY2022	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	721284000	usd
CY2024	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	371361000	usd
CY2024	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	181486000	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	241657000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-190174000	usd
CY2024	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	17472000	usd
CY2024	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	6242000	usd
CY2023	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	1471000	usd
CY2022	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	32679000	usd
CY2024	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11765000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	308565000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	55777000	usd
CY2024	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	200570000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	183498000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	163169000	usd
CY2024	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1561000	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	794000	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	997000	usd
CY2024	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2994000	usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	3672000	usd
CY2024	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	10472000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1828000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	10071000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-85186000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-498718000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	115830000	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2064000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-14862000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6293000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1337000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-139963000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	127789000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208357000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	348320000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	220531000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	207020000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208357000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	348320000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3891468000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	242870000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	148565000	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	55777000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	67499000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.69
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	163169000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2689317000	usd
CY2022	ste	Consideration Related To Equity Component Of Cantel Convertible Debt ConsiderationRelatedToEquityComponentOfCantelConvertibleDebt	175555000	usd
CY2022	ste	Consideration Related To Cantel Equity Compensation Programs ConsiderationRelatedToCantelEquityCompensationPrograms	18173000	usd
CY2022	ste	Reclassification To Cantel Convertible Debt Premium Liability ReclassificationToCantelConvertibleDebtPremiumLiability	175555000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	997000	usd
CY2022	ste	Noncontrolling Interest Increase From Contributions To Noncontrolling Interest Holders NoncontrollingInterestIncreaseFromContributionsToNoncontrollingInterestHolders	3672000	usd
CY2022	ste	Increase Decrease In Noncontrolling Interests Other IncreaseDecreaseInNoncontrollingInterestsOther	-146000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6544637000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	105813000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	110902000	usd
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	308565000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	40777000	usd
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	183498000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	794000	usd
CY2023	ste	Increase Decrease In Noncontrolling Interests Other IncreaseDecreaseInNoncontrollingInterestsOther	296000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6087172000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	380079000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	7947000	usd
CY2024	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11765000	usd
CY2024	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	67009000	usd
CY2024	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	2.03
CY2024	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	200570000	usd
CY2024	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1562000	usd
CY2024	ste	Noncontrolling Interest Increase From Contributions To Noncontrolling Interest Holders NoncontrollingInterestIncreaseFromContributionsToNoncontrollingInterestHolders	2994000	usd
CY2024	ste	Increase Decrease In Noncontrolling Interests Other IncreaseDecreaseInNoncontrollingInterestsOther	64000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6315346000	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of Operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. We offer our Customers a unique mix of innovative products and services. These include: consumable products, such as detergents, endoscopy accessories, barrier products, instruments and tools; and services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair, laboratory testing, outsourced reprocessing; and capital equipment, such as sterilizers, surgical tables, and automated endoscope reprocessors, and connectivity solutions such as operating room (“OR”) integrati</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate and report our financial information in three reportable business segments: Healthcare, Applied Sterilization Technologies ("AST"), and Life Sciences.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previously, we had four reportable business segments, however, as a result of the agreement to divest our Dental segment, Dental is presented as discontinued operations. Historical information has been retrospectively adjusted to reflect these changes for comparability purposes, as required. We describe our business segments in Note 13 titled "Business Segment Information."</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on March 31. References in this Annual Report to a particular "year," "fiscal," "fiscal year," or "year-end" mean our fiscal year. The significant accounting policies applied in preparing the accompanying consolidated financial statements of the Company are summarized below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the consolidation method to report our investment in our subsidiaries. Therefore, the accompanying consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. We eliminate intercompany accounts and transactions when we consolidate these accounts. Investments in equity of unconsolidated affiliates, over which the Company has significant influence, but not control, over the financial and operating polices, are accounted for primarily using the equity method. These investments are immaterial to the Company's consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Discontinued Operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 11, 2024, the Company announced its plan to sell substantially all of the net assets of its Dental segment for total cash consideration of $787,500, subject to customary adjustments, and up to an additional $12.5 million in contingent payment should the Dental business achieve certain revenue targets in fiscal 2025. The transaction is structured as an equity sale. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A component of an entity is reported in discontinued operations after meeting the criteria for held for sale classification if the disposition represents a strategic shift that has (or will have) a major effect on the entity's operations and financial results. We analyzed the quantitative and qualitative factors relevant to the divestiture of our Dental segment and determined that those conditions for discontinued operations presentation had been met prior to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">March 31, 2024. The Dental segment results of operations have been reclassified to income (loss) from discontinued operations in the Consolidated Statements of Income, and we have classified the Dental segment's assets and liabilities as held for sale for all periods presented in the accompanying Consolidated Balance Sheets. The transaction is anticipated to close in the first quarter of fiscal 2025. Therefore, the held for sale assets and liabilities are classified as current as of March 31, 2024. Our Consolidated Statements of Cash Flows include the financial results of the Dental segment for all periods presented. For additional information regarding this transaction and its effect on our financial reporting, refer to Note 4 titled, "Discontinued Operations" and Note 13 titled, "Business Segment Information."</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make certain estimates and assumptions when preparing financial statements according to accounting principles generally accepted in the United States ("U.S. GAAP") that affect the reported amounts of assets and liabilities at the financial statement dates and the reported amounts of revenues and expenses during the periods presented. These estimates and assumptions involve judgments with respect to many factors that are difficult to predict and are beyond our control. Actual results could be materially different from these estimates. We revise the estimates and assumptions as new information becomes available.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents and Supplemental Cash Flow Information. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are all highly liquid investments with a maturity of three months or less when purchased. We invest our excess cash in short-term instruments including money market funds, money market deposit accounts, bank savings accounts, and time deposits with major banks and financial institutions. We select investments in accordance with the criteria established in our investment policy. Our investment policy specifies, among other things, maturity, credit quality and concentration restrictions with the objective of preserving capital and maintaining adequate liquidity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information supplementing our Consolidated Statements of Cash Flows is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:55.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142,167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271,274</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,382 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received during the year for income tax refunds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,315 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,605 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition and Associated Liabilities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when obligations under the terms of the contract are satisfied and control of the promised products or services have transferred to the Customer. Revenues are measured at the amount of consideration that we expect to be paid in exchange for the products or services. Product revenue is recognized when control passes to the Customer, which is generally based on contract or shipping terms. Service revenue is recognized when the Customer benefits from the service, which occurs either upon completion of the service or as it is provided to the Customer. Our Customers include end users as well as dealers and distributors who market and sell our products. Our revenue is not contingent upon resale by the dealer or distributor, and we have no further obligations related to bringing about resale. Our standard return and restocking fee policies are applied to sales of products. Shipping and handling costs charged to Customers are included in Product revenues. The associated expenses are treated as fulfillment costs and are included in Cost of revenues. Revenues are reported net of sales and value-added taxes collected from Customers.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have individual Customer contracts that offer discounted pricing. Dealers and distributors may be offered sales incentives in the form of rebates. We reduce revenue for discounts and estimated returns, rebates, and other similar allowances in the same period the related revenues are recorded. The reduction in revenue for these items is estimated based on historical experience and trend analysis to the extent that it is probable that a significant reversal of revenue will not occur. Estimated returns are recorded gross on the Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In transactions that contain multiple performance obligations, such as when products, maintenance services, and other services are combined, we recognize revenue as each product is delivered or service is provided to the Customer. We allocate the total arrangement consideration to each performance obligation based on its relative standalone selling price, which is the price for the product or service when it is sold separately.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms vary by the type and location of the Customer and the products or services offered. Generally, the time between when revenue is recognized and when payment is due is not significant. We do not evaluate whether the selling price contains a financing component for contracts that have a duration of less than one year.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not capitalize sales commissions as substantially all of our sales commission programs have an amortization period of one year or less.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs to fulfill a contract are capitalized and amortized over the term of the contract if they are recoverable, directly related to a contract and generate resources that we will use to fulfill the contract in the future. At March 31, 2024, assets related to costs to fulfill a contract were not material to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 titled, "Business Segment Information" for disaggregation of revenue.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues consist of revenues generated from sales of consumables and capital equipment. These contracts are primarily based on a Customer’s purchase order and may include a Distributor, Dealer or Group Purchasing Organization ("GPO") agreement.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue for sales of products when control passes to the Customer, which generally occurs either when the products are shipped or when they are received by the Customer. Revenue related to capital equipment products is deferred until installation is complete if the capital equipment and installation are highly integrated and form a single performance obligation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenues</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our Healthcare and Life Sciences segments, service revenues include revenue generated from parts and labor associated with the maintenance, repair and installation of capital equipment. These contracts are primarily based on a Customer’s purchase order and may include a Distributor, Dealer, or GPO agreement. For maintenance, repair and installation of capital equipment, revenue is recognized upon completion of the service. Healthcare service revenues also include outsourced reprocessing services and instrument repairs. Contracts for outsourced reprocessing services are primarily based on an agreement with a Customer, ranging in length from several months to 15 years. Outsourced reprocessing services revenue is </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized ratably over the contract term using a time-based input measure, adjusted for volume and other performance metrics, to the extent that it is probable that a significant reversal of revenue will not occur. Contracts for instrument repairs are primarily based on a Customer’s purchase order, and the associated revenue is recognized upon completion of the repair. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer preventive maintenance and separately priced extended warranty agreements to our Customers, which require us to maintain and repair products over the duration of the contract. Generally, these contract terms are cancellable without penalty and range from one to five years. Amounts received under these Customer contracts are initially recorded as a service liability and are recognized as service revenue ratably over the contract term using a time-based input measure. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our AST segment, service revenues include contract sterilization and laboratory services. Sales contracts for contract sterilization and laboratory services are primarily based on a Customer’s purchase order and associated Customer agreement, and revenues are generally recognized upon completion of the service.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments received from Customers are based on invoices or billing schedules as established in contracts with Customers. Deferred revenue is recorded when payment is received in advance of performance under the contract. Deferred revenue is recognized as revenue upon completion of the performance obligation, which generally occurs within one year. During fiscal 2024, we recognized revenue of $66,690 that was included in our contract liability balance at the beginning of the period. During fiscal 2023, we recognized revenue of $72,914 that was included in our contract liability balance at the beginning of the period.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9 titled, "Additional Consolidated Balance Sheet Information" for deferred revenue balances.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Liabilities</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments received in advance of performance for cancellable preventive maintenance and separately priced extended warranty contracts are recorded as service liabilities. Service liabilities are recognized as revenue as performance is rendered under the contract. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9 titled, "Additional Consolidated Balance Sheet Information" for service liability balances.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations reflect only the performance obligations related to agreements for which we have a firm commitment from a Customer to purchase, and exclude variable consideration related to unsatisfied performance obligations. With regard to products, these remaining performance obligations include orders for capital equipment and consumables where control of the products has not passed to the customer. With regard</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to service, these remaining performance obligations primarily include installation, certification, and outsourced reprocessing services. As of March 31, 2024, the transaction price allocated to remaining performance obligations was approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,419,646</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We expect to recognize approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the transaction price within one year and approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> beyond one year. The remainder has yet to be scheduled for delivery.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Accounts receivable are presented at their face amount, less allowances for sales returns and uncollectible accounts. Accounts receivable consist of amounts billed and currently due from Customers and amounts earned but unbilled. We may obtain and perfect a security interest in products sold in the United States when we have a concern with the Customer's risk profile.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for uncollectible accounts receivable for estimated losses in the collection of amounts owed by Customers. We estimate the allowance based on analyzing a number of factors, including amounts written off historically, Customer payment practices, and general economic conditions. We also analyze significant Customer accounts on a regular basis and record a specific allowance when we become aware of a specific Customer’s inability to pay. As a result, the related accounts receivable are reduced to an amount that we reasonably believe is collectible.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for sales returns based upon known returns and estimated returns for both capital equipment and consumables. We estimate returns of capital equipment and consumables based upon recent historical experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> net. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of their cost and net realizable value determined by the first-in, first-out cost method. Inventory costs include material, labor, and overhead.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review inventory on an ongoing basis, considering factors such as deterioration, obsolescence, and other items. We record an allowance for estimated losses when the facts and circumstances indicate that particular inventories will not be usable. If future market conditions vary from those projected, and our estimates prove to be inaccurate, we may be required to write-down inventory values and record an adjustment to Cost of revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant, and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our property, plant, and equipment consists of land and land improvements, buildings and leasehold improvements, machinery and equipment, information systems, radioisotope (cobalt-60), and construction in progress. Property, plant, and equipment are presented at cost less accumulated depreciation and depletion. We capitalize additions and improvements. Repairs and maintenance are charged to expense as they are incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land is not depreciated and construction in progress is not depreciated until placed in service. Depreciation of most assets is computed on the cost less the estimated salvage value by using the straight-line method over the estimated remaining useful lives. Depletion of radioisotope is computed using the annual decay factor of the material, which is similar to the sum-of-the-years-digits method.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally depreciate or deplete property, plant, and equipment over the useful lives presented in the following table:</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful Life<br/>(years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-40</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-50</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-20</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information Systems</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-20</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radioisotope (cobalt-60)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we sell, retire, or dispose of property, plant, and equipment, we remove the asset’s cost and accumulated depreciation from our Consolidated Balance Sheet. We recognize the net gain or loss on the sale or disposition in the Consolidated Statements of Income in the period when the transaction occurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize interest costs incurred during the construction of long-lived assets. We capitalized interest costs of $7,094 and $6,366 for the years ended March 31, 2024 and 2023, respectively. Total interest expense for the years ended March 31, 2024, 2023, and 2022 was $144,351, $107,956, and $89,490, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Identifiable Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our identifiable intangible assets include product technology rights, trademarks, licenses, non-compete agreements, and Customer and vendor relationships. We record these assets at cost, or when acquired as part of a business acquisition, at estimated fair value. Determining the fair value of identifiable intangible assets requires management’s judgment and often involves the use of significant estimates and assumptions, including assumptions with respect to forecasted revenue growth rates, forecasted profit margins, and Customer attrition rates, among other items. We generally amortize identifiable intangible assets over periods ranging from 5 to 20 years using the straight-line method. Our intangible assets also include indefinite lived assets including certain trademarks and tradenames that were acquired in connection with business combinations. These assets are tested at least annually for impairment. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in marketable securities are stated at fair value and are included in Other assets on the Consolidated Balance Sheets. Changes in the fair value of these investments are recorded in the Interest and miscellaneous (income) expense line of the Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Impairment Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant, equipment, and identifiable intangible assets are reviewed for impairment when indicators of impairment exist and circumstances indicate that the carrying value of such assets may not be recoverable. Impaired assets are recorded at the lower of carrying value or estimated fair value. We monitor for such indicators on an ongoing basis and if an impairment exists, we record the loss in the Consolidated Statements of Income during that period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Retirement Obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We incur retirement obligations for certain assets. We record initial liabilities for the asset retirement obligations ("ARO") at fair value. Recognition of ARO includes estimating the present value of a liability and offsetting asset, the subsequent accretion of that liability and depletion of the asset, and a periodic review of the ARO liability estimates and discount rates used in the analysis. We provide additional information about our asset retirement obligations in Note 7 titled, “Property, Plant, and Equipment.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions of Business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets acquired and liabilities assumed in a business combination are accounted for at fair value on the date of acquisition. Costs related to the acquisition are expensed as incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We perform our annual impairment test for goodwill in the third quarter of each year. We may consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill. We may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. We review the book value compared to the fair value at the reporting unit level. We calculate the fair value of our reporting units based on the present value of estimated future cash flows. Management's judgment is necessary to evaluate the impact of operating and macroeconomic changes and to estimate future cash flows to measure fair value. Assumptions used in our impairment evaluations, such as forecasted growth rates and cost of capital, are consistent with internal projections, strategic plans, and operating plans. We believe such assumptions and estimates are also comparable to those that would be used by other marketplace participants.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance Liabilities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record a liability for self-insured risks that we retain for general and product liabilities, workers’ compensation, and automobile liabilities based on actuarial calculations. We use our historical loss experience and actuarial methods to calculate the liability. This liability includes estimates for both known losses and incurred but not reported claims. We review the assumptions used to calculate the estimated liability at least annually to evaluate the adequacy of the amount recorded. We maintain insurance policies to cover losses greater than our estimated liability, which are subject to the terms and conditions of those policies. We are also self-insured for certain employee medical claims. We estimate a liability for incurred but not reported claims based upon recent claims experience. Liability amounts are recorded in the "Accrued expenses and other" and "Other liabilities" line of our Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Benefit Plans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We sponsor defined benefit pension plans. We also sponsor a post-retirement benefits plan for certain former employees. We determine our costs and obligations related to these plans by evaluating input from third-party professional advisers. These costs and obligations are affected by assumptions including the discount rate, expected long-term rate of return on plan assets, the annual rate of change in compensation for eligible employees, estimated changes in costs of healthcare benefits, and other factors. We review the assumptions used on an annual basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize an asset for the overfunded status or a liability for the underfunded status of defined benefit pension and post-retirement benefits plans in our Consolidated Balance Sheets. This amount is measured as the difference between the fair value of plan assets and the benefit obligation (the projected benefit obligation for pension plans and the accumulated post-retirement benefit obligation for other post-retirement benefit plans). Changes in the funded status of the plans are recorded in other comprehensive income in the year they occur. We measure plan assets and obligations as of the balance sheet date. We provide additional information about our pension and other post-retirement benefits plans in Note 11 titled, “Benefit Plans.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except for long-term debt, our financial instruments are highly liquid or have short-term maturities. We provide additional information about the fair value of our financial instruments in Note 19 titled, “Fair Value Measurements.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Most of our operations use their local currency as their functional currency. Financial statements of subsidiaries are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and a weighted average exchange rate for each period for revenues, expenses, gains and losses. Translation adjustments for subsidiaries whose local currency is their functional currency are recorded as a component of accumulated other comprehensive income (loss) within equity. Transaction gains and losses resulting from fluctuations in currency exchange rates on transactions denominated in currencies other than the functional currency are recognized as incurred in the accompanying Consolidated Statements of Income, except for certain intercompany balances designated as long-term in nature.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward and Swap Contracts. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We enter into foreign currency forward contracts to hedge assets and liabilities denominated in foreign currencies, including intercompany transactions. We may also enter into commodity swap contracts to hedge price changes in nickel that impact raw materials included in our Cost of revenues. We may also hold forward foreign exchange contracts to hedge a portion of our expected non-U.S. dollar denominated earnings against our reporting currency, the U.S. dollar. We do not use derivative financial instruments for speculative purposes. These contracts are marked to market, with gains and losses recognized within Selling, general, and administrative expenses or Cost of revenues in the accompanying Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranty.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Warranties are provided on the sale of certain of our products and services and an accrual for estimated future claims is recorded at the time revenue is recognized. We estimate warranty expense based primarily on historical warranty claim experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record shipping and handling costs in Cost of revenues. Shipping and handling costs charged to Customers are recorded as revenues in the period the product revenues are recognized.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs incurred for communicating, advertising and promoting our products are generally expensed when incurred as a component of Selling, general, and administrative expenses. We incurred $25,474, $21,668, and $15,599 of advertising costs during the years ended March 31, 2024, 2023, and 2022, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We incur research and development costs associated with commercial products and expense these costs as incurred. If a Customer reimburses us for research and development costs, the costs are charged to the related contracts as Cost of revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We defer income taxes for all temporary differences between pre-tax financial and taxable income and between the book and tax basis of assets and liabilities. We record valuation allowances to reduce net deferred tax assets to an amount that we expect will more-likely-than-not be realized. In making such a determination, we consider all available information, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and if applicable, any carryback claims that can be filed. In the event we were to determine that we would be able to realize our deferred income tax assets in the future in excess of their net recorded amount, we would make an adjustment to the valuation allowance which would reduce the provision for income taxes and the effective tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate uncertain tax positions in accordance with a two-step process. The first step is recognition: The determination of whether or not it is more-likely-than-not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, we presume that the position will be examined by the appropriate tax authority and that the tax authority will have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not threshold is measured to determine the amount of benefit to recognize in the financial statements. The measurement process requires the determination of the range of possible settlement amounts and the probability of achieving each of the possible settlements. The tax position is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. No tax benefits are recognized for positions that do not meet the more-likely-than-not threshold. Tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not recognition threshold are derecognized in the first subsequent financial reporting period in which the threshold is no longer met. We describe income taxes further in Note 10 titled, “Income Taxes.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We describe share-based compensation in Note 16 titled, “Share-Based Compensation.” We measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. We record liability awards at fair value each reporting period, and the change in fair value is reflected as share-based compensation expense in our Consolidated Statements of Income. The expense is classified as Cost of revenues, Selling, general, and administrative expenses or Research and development expenses in a manner consistent with the employee’s compensation and benefits. These costs are recognized in the Consolidated Statements of Income over the period during which an employee is required to provide service in exchange for the award. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recognize restructuring expenses associated with actions designed to enhance profitability and improve efficiency of our operations. Severance and other compensation related costs include severance, medical benefits, and other termination benefits. For ongoing benefit arrangements, a liability is recognized when it is probable that employees will be entitled to benefits and the amount can be reasonably estimated. For one-time benefit arrangements, a liability is incurred and must be accrued at the date the plan is communicated to employees, unless they will be retained beyond a minimum retention period. In this case, the liability is calculated at the date the plan is communicated to employees and is accrued ratably over the future service period. Asset impairment expenses primarily relate to adjustments in the carrying value of facilities and machinery and equipment associated with restructuring actions to their estimated fair value. In addition, the remaining useful lives of other property, plant, and equipment associated with the restructuring actions are re-evaluated, which may result in the acceleration of depreciation and amortization of certain assets. Other restructuring expenses are expensed as incurred. Product rationalization charges relate to inventory write-downs and are recognized in Cost of revenues in the Consolidated Statements of Income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our recent restructurings, refer to Note 2 titled, "Restructuring." </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Impacting the Company </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently Issued Accounting Standards Impacting the Company are presented in the following table:</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:14.136%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.331%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.609%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Issuance</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Adoption</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect on the financial statements or other significant matters</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standards that have been adopted in fiscal 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2022-04 "Liabilities - Supplier Finance Programs (Subtopic 405-50) Disclosure of Supplier Finance Program Obligations."</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The standard provides guidance to enhance the transparency of disclosures for entities that utilize supplier finance programs to include information about the key terms of the programs and present a rollforward of any obligations under the program where those obligations are presented in the balance sheet.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We adopted this standard in fiscal 2024 with no material impact to our consolidated financial statements.</span></div></td></tr><tr><td colspan="27" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standards that have not yet been adopted.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2023-07 "Segment Reporting (Topic 280)<br/>Improvements to Reportable Segment Disclosures."</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The standard provides guidance to enhance disclosures related to reportable segment expenses, including requirements to disclose significant segment expenses that are regularly provided to the Chief Operating Decision Maker ("CODM"), the title and position of the CODM and a description of how the CODM uses the information to make decisions regarding the allocation of resources. The standard also requires disclosure of certain segment information currently required annually to be reported on an interim basis. The amendments in this standard are effective for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024.</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are currently assessing the impact of this standard update on our disclosures in the notes to the consolidated financial statements.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2023-09 "Income Taxes (Topic 740) Improvements to Income Tax Disclosures."</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The standard provides guidance to enhance disclosures related to income taxes paid (net of refunds), requiring disaggregation by federal, state, and foreign, and disclosure of income taxes paid (net of refunds received) by individual jurisdictions that represent greater than 5% of the total. The standard also requires disclosure of income (loss) from continuing operations before income taxes, disaggregated between domestic and foreign, and income tax expense (or benefit) disaggregated by federal, state, and foreign. Finally, the standard removes the requirement for certain disclosures related to changes in unrecognized tax benefits and certain amounts of temporary differences. The amendments in this standard are effective for annual periods beginning after December 15, 2024.</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are currently assessing the impact of this standard update on our disclosures in the notes to the consolidated financial statements.</span></div></td></tr></table></div>
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make certain estimates and assumptions when preparing financial statements according to accounting principles generally accepted in the United States ("U.S. GAAP") that affect the reported amounts of assets and liabilities at the financial statement dates and the reported amounts of revenues and expenses during the periods presented. These estimates and assumptions involve judgments with respect to many factors that are difficult to predict and are beyond our control. Actual results could be materially different from these estimates. We revise the estimates and assumptions as new information becomes available.</span></div>
CY2024	us-gaap	Interest Paid InterestPaid	142167000	usd
CY2023	us-gaap	Interest Paid InterestPaid	108470000	usd
CY2022	us-gaap	Interest Paid InterestPaid	84696000	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	271274000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	254661000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	138382000	usd
CY2024	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	19175000	usd
CY2023	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	2315000	usd
CY2022	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	4605000	usd
CY2024	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	66690000	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	72914000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1419646000	usd
CY2024	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	7094000	usd
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	6366000	usd
CY2024	us-gaap	Interest Costs Incurred InterestCostsIncurred	144351000	usd
CY2023	us-gaap	Interest Costs Incurred InterestCostsIncurred	107956000	usd
CY2022	us-gaap	Interest Costs Incurred InterestCostsIncurred	89490000	usd
CY2024	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Impairment Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant, equipment, and identifiable intangible assets are reviewed for impairment when indicators of impairment exist and circumstances indicate that the carrying value of such assets may not be recoverable. Impaired assets are recorded at the lower of carrying value or estimated fair value. We monitor for such indicators on an ongoing basis and if an impairment exists, we record the loss in the Consolidated Statements of Income during that period.</span></div>
CY2024	us-gaap	Advertising Expense AdvertisingExpense	25474000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	21668000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	15599000	usd
CY2024	us-gaap	Restructuring And Related Cost Expected Number Of Positions Eliminated RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated	300	unit
CY2024	ste	Asset Acquisition Tax Deductible Goodwill Expected AssetAcquisitionTaxDeductibleGoodwillExpected	60000000	usd
CY2022Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	3700
CY2022Q1	ste	Cantel Acquisition Assumed Debt Obligations CantelAcquisitionAssumedDebtObligations	721284000	usd
CY2022Q1	ste	Deferred Consideration DeferredConsideration	50000	usd
CY2024Q1	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	195667000	usd
CY2023Q1	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	4863000	usd
CY2022Q1	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	427035000	usd
CY2024	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	25526000	usd
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	23486000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	201905000	usd
CY2024	ste	Loss On Classification As Held For Sale LossOnClassificationAsHeldForSale	206444000	usd
CY2023	ste	Loss On Classification As Held For Sale LossOnClassificationAsHeldForSale	0	usd
CY2022	ste	Loss On Classification As Held For Sale LossOnClassificationAsHeldForSale	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	490565000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0.243
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0.139
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0.205
CY2023	ste	Non Deductible Goodwill Impairment NonDeductibleGoodwillImpairment	207367000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	3938976000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	7024000	usd
CY2023	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-18477000	usd
CY2023	ste	Goodwill Decrease From Divestitures GoodwillDecreaseFromDivestitures	-2358000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-45946000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	3879219000	usd
CY2024	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	200086000	usd
CY2024	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-2573000	usd
CY2024	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-6020000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4070712000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3390779000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1271497000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3080820000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1004121000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	14250000	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	268319000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	259676000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	264607000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	270365000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	261498000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	255383000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	250617000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	248061000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	245942000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	220431000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	98304000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	93971000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	374182000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	325609000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	43893000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	35601000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	674535000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	604410000	usd
CY2024Q1	us-gaap	Land Land	90134000	usd
CY2023Q1	us-gaap	Land Land	77757000	usd
CY2024Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	724492000	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	658108000	usd
CY2024Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1075082000	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	959952000	usd
CY2024Q1	ste	Computer Softwareand Hardwaregross ComputerSoftwareandHardwaregross	256671000	usd
CY2023Q1	ste	Computer Softwareand Hardwaregross ComputerSoftwareandHardwaregross	240933000	usd
CY2024Q1	us-gaap	Materials Supplies And Other MaterialsSuppliesAndOther	692642000	usd
CY2023Q1	us-gaap	Materials Supplies And Other MaterialsSuppliesAndOther	637920000	usd
CY2024Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	500106000	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	472206000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3339127000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3046876000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1573947000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1414101000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1765180000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1632775000	usd
CY2024	us-gaap	Depreciation Depreciation	181722000	usd
CY2023	us-gaap	Depreciation Depreciation	165019000	usd
CY2022	us-gaap	Depreciation Depreciation	176298000	usd
CY2022Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	13543000	usd
CY2023	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	86000	usd
CY2023	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	625000	usd
CY2023	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	104000	usd
CY2023	us-gaap	Asset Retirement Obligation Foreign Currency Translation Gain Loss AssetRetirementObligationForeignCurrencyTranslationGainLoss	23000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	13131000	usd
CY2024	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	253000	usd
CY2024	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	144000	usd
CY2024	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	311000	usd
CY2024	us-gaap	Asset Retirement Obligation Foreign Currency Translation Gain Loss AssetRetirementObligationForeignCurrencyTranslationGainLoss	107000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	13658000	usd
CY2024Q1	ste	Term Loan Current Portion TermLoanCurrentPortion	41250000	usd
CY2023Q1	ste	Term Loan Current Portion TermLoanCurrentPortion	27500000	usd
CY2024Q1	ste	Delayed Draw Term Loan Current Portion DelayedDrawTermLoanCurrentPortion	44688000	usd
CY2023Q1	ste	Delayed Draw Term Loan Current Portion DelayedDrawTermLoanCurrentPortion	32500000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	85938000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	60000000	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	484529000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	301672000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	17988000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	21444000	usd
CY2024Q1	ste	Term Loan Long Term Portion TermLoanLongTermPortion	3750000	usd
CY2023Q1	ste	Term Loan Long Term Portion TermLoanLongTermPortion	45000000	usd
CY2024Q1	ste	Delayed Draw Term Loan Long Term Portion DelayedDrawTermLoanLongTermPortion	548438000	usd
CY2023Q1	ste	Delayed Draw Term Loan Long Term Portion DelayedDrawTermLoanLongTermPortion	593125000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	3120162000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	3018655000	usd
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	3206100000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	3078655000	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	484529000	usd
CY2021Q2	ste	Delayed Draw Term Loan Long Term Portion DelayedDrawTermLoanLongTermPortion	650000000	usd
CY2021Q2	ste	Debt Instrument Convertible Units Of Property Reference DebtInstrumentConvertibleUnitsOfPropertyReference	25.0843
CY2021Q2	ste	Debt Instrument Convertible Parent Shares DebtInstrumentConvertibleParentShares	8.4752	shares
CY2021Q2	ste	Debt Instrument Convertible Cash Per One Thousand Dollars Ratio DebtInstrumentConvertibleCashPerOneThousandDollarsRatio	424.68
CY2021Q2	ste	Debt Instrument Convertible Increase In Conversion Rate Shares DebtInstrumentConvertibleIncreaseInConversionRateShares	0.9931	shares
CY2021Q2	ste	Debt Instrument Convertible Stock Price DebtInstrumentConvertibleStockPrice	81.3520

CY2024Q2

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

98900010

shares

CY2023

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.84

CY2024

us-gaap

Restructuring Costs

RestructuringCosts

26045000

usd

CY2023

us-gaap

Operating Expenses

OperatingExpenses

1189625000

usd

CY2022

us-gaap

Operating Income Loss

OperatingIncomeLoss

477815000

usd

CY2023

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-2879000

usd

CY2022

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

-111012000

usd

CY2024

us-gaap

Profit Loss

ProfitLoss

380079000

usd

CY2023

us-gaap

Profit Loss

ProfitLoss

105813000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

242870000

usd

CY2024

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

1840000

usd

CY2022

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-1018000

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

107030000

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

243888000

usd

CY2024

us-gaap

Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

-7211000

usd

CY2023

us-gaap

Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

-109638000

usd

CY2024

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-7947000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-110902000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-148565000

usd

CY2024

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

370292000

usd

CY2023

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

-3872000

usd

CY2022

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

95323000

usd

CY2022

us-gaap

Share Based Compensation

ShareBasedCompensation

57660000

usd

CY2023

us-gaap

Gain Loss On Sale Of Property Plant Equipment

GainLossOnSaleOfPropertyPlantEquipment

-22193000

usd

CY2022

us-gaap

Gain Loss On Sale Of Property Plant Equipment

GainLossOnSaleOfPropertyPlantEquipment

-15117000

usd

CY2024

us-gaap

Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax

-736000

usd

CY2024

dei

Entity Central Index Key

EntityCentralIndexKey

0001757898

CY2024

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--03-31

CY2024

dei

Document Period End Date

DocumentPeriodEndDate

2024-03-31

CY2024

dei

Amendment Flag

AmendmentFlag

false

CY2024

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2024

CY2024

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

FY

CY2024Q2

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

98900010

shares

CY2023Q3

dei

Entity Public Float

EntityPublicFloat

21614000000

usd

CY2023Q1

us-gaap

Indefinite Lived Intangible Assets Excluding Goodwill

IndefiniteLivedIntangibleAssetsExcludingGoodwill

14250000

usd

CY2024

dei

Document Annual Report

DocumentAnnualReport

true

CY2024

dei

Document Period End Date

DocumentPeriodEndDate

2024-03-31

CY2024

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--03-31

CY2024

dei

Document Transition Report

DocumentTransitionReport

false

CY2024

dei

Entity File Number

EntityFileNumber

001-38848

CY2024

dei

Entity Registrant Name

EntityRegistrantName

STERIS plc

CY2024

dei

Entity Incorporation State Country Code

EntityIncorporationStateCountryCode

L2

CY2024

dei

Entity Tax Identification Number

EntityTaxIdentificationNumber

98-1455064

CY2024

dei

Entity Address Address Line1

EntityAddressAddressLine1

70 Sir John Rogerson's Quay,

CY2024

dei

Entity Address City Or Town

EntityAddressCityOrTown

Dublin 2,

CY2024

dei

Entity Address Country

EntityAddressCountry

IE

CY2024

dei

Entity Address Postal Zip Code

EntityAddressPostalZipCode

D02 R296

CY2024

dei

Country Region

CountryRegion

353

CY2024

dei

City Area Code

CityAreaCode

1

CY2024

dei

Local Phone Number

LocalPhoneNumber

232 2000

CY2024

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

Yes

CY2024

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2024

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2024

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

CY2024

dei

Entity Filer Category

EntityFilerCategory

Large Accelerated Filer

CY2024

dei

Entity Small Business

EntitySmallBusiness

false

CY2024

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

false

CY2024

dei

Icfr Auditor Attestation Flag

IcfrAuditorAttestationFlag

true

CY2024

dei

Document Fin Stmt Error Correction Flag

DocumentFinStmtErrorCorrectionFlag

false

CY2024

dei

Entity Shell Company

EntityShellCompany

false

CY2023Q3

dei

Entity Public Float

EntityPublicFloat

21614000000

usd

CY2024

dei

Auditor Firm

AuditorFirmId

42

CY2024

dei

Auditor Name

AuditorName

Ernst & Young LLP

CY2024

dei

Auditor Location

AuditorLocation

Cleveland, Ohio

CY2024Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

207020000

usd

CY2023Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

208357000

usd

CY2024Q1

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

22984000

usd

CY2023Q1

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

19284000

usd

CY2024Q1

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

1008315000

usd

CY2023Q1

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

864988000

usd

CY2024Q1

us-gaap

Inventory Net

InventoryNet

674535000

usd

CY2023Q1

us-gaap

Inventory Net

InventoryNet

604410000

usd

CY2024Q1

us-gaap

Other Prepaid Expense Current

OtherPrepaidExpenseCurrent

174349000

usd

CY2023Q1

us-gaap

Other Prepaid Expense Current

OtherPrepaidExpenseCurrent

176107000

usd

CY2024Q1

us-gaap

Assets Of Disposal Group Including Discontinued Operation Current

AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent

804904000

usd

CY2023Q1

us-gaap

Assets Of Disposal Group Including Discontinued Operation Current

AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent

157580000

usd

CY2024Q1

us-gaap

Assets Current

AssetsCurrent

2869123000

usd

CY2023Q1

us-gaap

Assets Current

AssetsCurrent

2011442000

usd

CY2024Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1765180000

usd

CY2023Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1632775000

usd

CY2024Q1

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

173201000

usd

CY2023Q1

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

166553000

usd

CY2024Q1

us-gaap

Goodwill

4070712000

usd

CY2023Q1

us-gaap

Goodwill

3879219000

usd

CY2024Q1

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

2119282000

usd

CY2023Q1

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

2076699000

usd

CY2024Q1

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

66199000

usd

CY2023Q1

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

77892000

usd

CY2024Q1

us-gaap

Disposal Group Including Discontinued Operation Assets Noncurrent

DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent

0

usd

CY2023Q1

us-gaap

Disposal Group Including Discontinued Operation Assets Noncurrent

DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent

977259000

usd

CY2024Q1

us-gaap

Assets

11063697000

usd

CY2023Q1

us-gaap

Assets

10821839000

usd

CY2024Q1

us-gaap

Accounts Payable Current

AccountsPayableCurrent

251723000

usd

CY2023Q1

us-gaap

Accounts Payable Current

AccountsPayableCurrent

264165000

usd

CY2024Q1

us-gaap

Accrued Income Taxes Current

AccruedIncomeTaxesCurrent

13640000

usd

CY2023Q1

us-gaap

Accrued Income Taxes Current

AccruedIncomeTaxesCurrent

40477000

usd

CY2024Q1

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

164831000

usd

CY2023Q1

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

118463000

usd

CY2024Q1

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

31239000

usd

CY2023Q1

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

30065000

usd

CY2024Q1

us-gaap

Short Term Borrowings

ShortTermBorrowings

85938000

usd

CY2023Q1

us-gaap

Short Term Borrowings

ShortTermBorrowings

60000000

usd

CY2024Q1

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

319744000

usd

CY2023Q1

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

298032000

usd

CY2024Q1

us-gaap

Liabilities Of Disposal Group Including Discontinued Operation Current

LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent

64012000

usd

CY2023Q1

us-gaap

Liabilities Of Disposal Group Including Discontinued Operation Current

LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent

50642000

usd

CY2024Q1

us-gaap

Liabilities Current

LiabilitiesCurrent

931127000

usd

CY2023Q1

us-gaap

Liabilities Current

LiabilitiesCurrent

861844000

usd

CY2024Q1

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

3120162000

usd

CY2023Q1

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

3018655000

usd

CY2024Q1

us-gaap

Deferred Income Taxes And Other Tax Liabilities Noncurrent

DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent

479688000

usd

CY2023Q1

us-gaap

Deferred Income Taxes And Other Tax Liabilities Noncurrent

DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent

617538000

usd

CY2024Q1

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

145828000

usd

CY2023Q1

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

139557000

usd

CY2024Q1

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

71546000

usd

CY2023Q1

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

76137000

usd

CY2024Q1

us-gaap

Liabilities Of Disposal Group Including Discontinued Operation Noncurrent

LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent

0

usd

CY2023Q1

us-gaap

Liabilities Of Disposal Group Including Discontinued Operation Noncurrent

LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent

20936000

usd

CY2024Q1

us-gaap

Liabilities

4748351000

usd

CY2023Q1

us-gaap

Liabilities

4734667000

usd

CY2024Q1

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2023Q1

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2024Q1

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.001

CY2024Q1

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

500000000

shares

CY2024Q1

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

98883000

shares

CY2024Q1

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

98883000

shares

CY2023Q1

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

98629000

shares

CY2023Q1

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

98629000

shares

CY2024Q1

us-gaap

Common Stock Value

CommonStockValue

4543176000

usd

CY2023Q1

us-gaap

Common Stock Value

CommonStockValue

4486375000

usd

CY2024Q1

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

2087645000

usd

CY2023Q1

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

1911533000

usd

CY2024Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-328657000

usd

CY2023Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-320710000

usd

CY2024Q1

us-gaap

Stockholders Equity

StockholdersEquity

6302164000

usd

CY2023Q1

us-gaap

Stockholders Equity

StockholdersEquity

6077198000

usd

CY2024Q1

us-gaap

Minority Interest

MinorityInterest

13182000

usd

CY2023Q1

us-gaap

Minority Interest

MinorityInterest

9974000

usd

CY2024Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

6315346000

usd

CY2023Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

6087172000

usd

CY2024Q1

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

11063697000

usd

CY2023Q1

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

10821839000

usd

CY2024

us-gaap

Revenues

5138701000

usd

CY2023

us-gaap

Revenues

4536266000

usd

CY2022

us-gaap

Revenues

4223403000

usd

CY2024

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

2920541000

usd

CY2023

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

2555540000

usd

CY2022

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

2340396000

usd

CY2022

us-gaap

Gross Profit

GrossProfit

1883007000

usd

CY2024

us-gaap

Operating Expenses

OperatingExpenses

1382042000

usd

CY2024

us-gaap

Operating Income Loss

OperatingIncomeLoss

836118000

usd

CY2023

us-gaap

Operating Income Loss

OperatingIncomeLoss

791101000

usd

CY2024

us-gaap

Interest Expense

InterestExpense

144351000

usd

CY2023

us-gaap

Interest Expense

InterestExpense

107956000

usd

CY2022

us-gaap

Interest Expense

InterestExpense

89490000

usd

CY2024

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

0

usd

CY2023

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

0

usd

CY2022

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

27806000

usd

CY2024

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

11043000

usd

CY2024

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

-133308000

usd

CY2023

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

-110835000

usd

CY2024

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

702810000

usd

CY2023

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

680266000

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

366803000

usd

CY2024

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

149530000

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

124069000

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

82344000

usd

CY2024

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

553280000

usd

CY2023

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

556197000

usd

CY2022

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

284459000

usd

CY2024

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-173201000

usd

CY2023

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-450384000

usd

CY2022

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-41589000

usd

CY2023

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-1217000

usd

CY2024

us-gaap

Net Income Loss

NetIncomeLoss

378239000

usd

CY2024

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

5.58

CY2023

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

5.59

CY2022

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

2.93

CY2024

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-1.75

CY2023

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-4.52

CY2022

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-0.43

CY2024

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

3.83

CY2023

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.07

CY2022

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.50

CY2024

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

5.55

CY2023

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

5.56

CY2022

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

2.90

CY2024

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-1.74

CY2023

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-4.49

CY2022

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-0.42

CY2024

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

3.81

CY2023

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.07

CY2022

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

2.48

CY2024

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

2.03

CY2023

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.84

CY2022

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.69

CY2024

us-gaap

Profit Loss

ProfitLoss

380079000

usd

CY2023

us-gaap

Profit Loss

ProfitLoss

105813000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

242870000

usd

CY2024

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

1840000

usd

CY2023

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-1217000

usd

CY2022

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-1018000

usd

CY2024

us-gaap

Net Income Loss

NetIncomeLoss

378239000

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

107030000

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

243888000

usd

CY2024

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax

-155000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax

521000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax

507000

usd

CY2023

us-gaap

Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax

-1264000

usd

CY2022

us-gaap

Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax

6795000

usd

CY2022

us-gaap

Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax

OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

-155360000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

242870000

usd

CY2024

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

565244000

usd

CY2023

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

552897000

usd

CY2022

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

553104000

usd

CY2024

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-131412000

usd

CY2023

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-185913000

usd

CY2022

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-106620000

usd

CY2022

us-gaap

Proceeds From Sale Of Other Investments

ProceedsFromSaleOfOtherInvestments

0

usd

CY2024

us-gaap

Payments To Acquire Investments

PaymentsToAcquireInvestments

1500000

usd

CY2023

us-gaap

Payments To Acquire Investments

PaymentsToAcquireInvestments

0

usd

CY2024

us-gaap

Share Based Compensation

ShareBasedCompensation

56535000

usd

CY2023

us-gaap

Share Based Compensation

ShareBasedCompensation

38951000

usd

CY2024

us-gaap

Gain Loss On Sale Of Property Plant Equipment

GainLossOnSaleOfPropertyPlantEquipment

-24997000

usd

CY2024

ste

Loss On Classification As Held For Sale

LossOnClassificationAsHeldForSale

206444000

usd

CY2023

ste

Loss On Classification As Held For Sale

LossOnClassificationAsHeldForSale

0

usd

CY2022

ste

Loss On Classification As Held For Sale

LossOnClassificationAsHeldForSale

0

usd

CY2024

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

-873000

usd

CY2023

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

67000

usd

CY2022

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

874000

usd

CY2024

us-gaap

Gain Loss On Sale Of Investments

GainLossOnSaleOfInvestments

546000

usd

CY2023

us-gaap

Gain Loss On Sale Of Investments

GainLossOnSaleOfInvestments

0

usd

CY2022

us-gaap

Gain Loss On Sale Of Investments

GainLossOnSaleOfInvestments

0

usd

CY2024

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

0

usd

CY2023

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

0

usd

CY2022

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

27806000

usd

CY2024

ste

Amortization Of Inventory Fair Value Adjustments

AmortizationOfInventoryFairValueAdjustments

4822000

usd

CY2023

ste

Amortization Of Inventory Fair Value Adjustments

AmortizationOfInventoryFairValueAdjustments

7363000

usd

CY2022

ste

Amortization Of Inventory Fair Value Adjustments

AmortizationOfInventoryFairValueAdjustments

66663000

usd

CY2024

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

0

usd

CY2023

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

490565000

usd

CY2022

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

0

usd

CY2024

us-gaap

Other Noncash Income Expense

OtherNoncashIncomeExpense

-12316000

usd

CY2023

us-gaap

Other Noncash Income Expense

OtherNoncashIncomeExpense

24832000

usd

CY2022

us-gaap

Other Noncash Income Expense

OtherNoncashIncomeExpense

21639000

usd

CY2024

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

128069000

usd

CY2023

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

133304000

usd

CY2022

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

51969000

usd

CY2024

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

37450000

usd

CY2023

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

123921000

usd

CY2022

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

102922000

usd

CY2024

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

1552000

usd

CY2023

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

24086000

usd

CY2022

us-gaap

Increase Decrease In Prepaid Deferred Expense And Other Assets

IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

-7126000

usd

CY2024

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

-18962000

usd

CY2023

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

53342000

usd

CY2022

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

14887000

usd

CY2024

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

39955000

usd

CY2023

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

-22054000

usd

CY2022

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

-16398000

usd

CY2024

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

973274000

usd

CY2023

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

756947000

usd

CY2022

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

684811000

usd

CY2024

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

360326000

usd

CY2023

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

361969000

usd

CY2022

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

287563000

usd

CY2024

us-gaap

Proceeds From Sale Of Property Plant And Equipment

ProceedsFromSaleOfPropertyPlantAndEquipment

7381000

usd

CY2023

us-gaap

Proceeds From Sale Of Property Plant And Equipment

ProceedsFromSaleOfPropertyPlantAndEquipment

14587000

usd

CY2022

us-gaap

Proceeds From Sale Of Property Plant And Equipment

ProceedsFromSaleOfPropertyPlantAndEquipment

1741000

usd

CY2024

us-gaap

Proceeds From Divestiture Of Businesses

ProceedsFromDivestitureOfBusinesses

9458000

usd

CY2023

us-gaap

Proceeds From Divestiture Of Businesses

ProceedsFromDivestitureOfBusinesses

6624000

usd

CY2022

us-gaap

Proceeds From Divestiture Of Businesses

ProceedsFromDivestitureOfBusinesses

169712000

usd

CY2024

us-gaap

Proceeds From Sale Of Other Investments

ProceedsFromSaleOfOtherInvestments

3882000

usd

CY2023

us-gaap

Proceeds From Sale Of Other Investments

ProceedsFromSaleOfOtherInvestments

0

usd

CY2022

us-gaap

Payments To Acquire Investments

PaymentsToAcquireInvestments

0

usd

CY2024

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

546256000

usd

CY2023

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

42572000

usd

CY2022

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

550449000

usd

CY2024

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-887361000

usd

CY2023

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-383330000

usd

CY2022

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-666559000

usd

CY2024

us-gaap

Proceeds From Issuance Of Senior Long Term Debt

ProceedsFromIssuanceOfSeniorLongTermDebt

0

usd

CY2023

us-gaap

Proceeds From Issuance Of Senior Long Term Debt

ProceedsFromIssuanceOfSeniorLongTermDebt

0

usd

CY2022

us-gaap

Proceeds From Issuance Of Senior Long Term Debt

ProceedsFromIssuanceOfSeniorLongTermDebt

1350000000

usd

CY2024

us-gaap

Proceeds From Issuance Of Debt

ProceedsFromIssuanceOfDebt

0

usd

CY2023

us-gaap

Proceeds From Issuance Of Debt

ProceedsFromIssuanceOfDebt

0

usd

CY2022

us-gaap

Proceeds From Issuance Of Debt

ProceedsFromIssuanceOfDebt

650000000

usd

CY2024

ste

Repayments Of Term Loans

RepaymentsOfTermLoans

60000000

usd

CY2023

ste

Repayments Of Term Loans

RepaymentsOfTermLoans

156875000

usd

CY2022

ste

Repayments Of Term Loans

RepaymentsOfTermLoans

345000000

usd

CY2024

us-gaap

Payments For Repurchase Of Private Placement

PaymentsForRepurchaseOfPrivatePlacement

0

usd

CY2023

us-gaap

Payments For Repurchase Of Private Placement

PaymentsForRepurchaseOfPrivatePlacement

91000000

usd

CY2022

us-gaap

Payments For Repurchase Of Private Placement

PaymentsForRepurchaseOfPrivatePlacement

721284000

usd

CY2024

us-gaap

Repayments Of Convertible Debt

RepaymentsOfConvertibleDebt

0

usd

CY2023

us-gaap

Repayments Of Convertible Debt

RepaymentsOfConvertibleDebt

0

usd

CY2022

us-gaap

Repayments Of Convertible Debt

RepaymentsOfConvertibleDebt

371361000

usd

CY2024

us-gaap

Proceeds From Repayments Of Lines Of Credit

ProceedsFromRepaymentsOfLinesOfCredit

181486000

usd

CY2023

us-gaap

Proceeds From Repayments Of Lines Of Credit

ProceedsFromRepaymentsOfLinesOfCredit

241657000

usd

CY2022

us-gaap

Proceeds From Repayments Of Lines Of Credit

ProceedsFromRepaymentsOfLinesOfCredit

-190174000

usd

CY2024

us-gaap

Payments Of Financing Costs

PaymentsOfFinancingCosts

0

usd

CY2023

us-gaap

Payments Of Financing Costs

PaymentsOfFinancingCosts

0

usd

CY2022

us-gaap

Payments Of Financing Costs

PaymentsOfFinancingCosts

17472000

usd

CY2024

us-gaap

Payments Of Merger Related Costs Financing Activities

PaymentsOfMergerRelatedCostsFinancingActivities

6242000

usd

CY2023

us-gaap

Payments Of Merger Related Costs Financing Activities

PaymentsOfMergerRelatedCostsFinancingActivities

1471000

usd

CY2022

us-gaap

Payments Of Merger Related Costs Financing Activities

PaymentsOfMergerRelatedCostsFinancingActivities

32679000

usd

CY2024

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

11765000

usd

CY2023

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

308565000

usd

CY2022

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

55777000

usd

CY2024

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

200570000

usd

CY2023

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

183498000

usd

CY2022

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

163169000

usd

CY2024

us-gaap

Payments To Minority Shareholders

PaymentsToMinorityShareholders

1561000

usd

CY2023

us-gaap

Payments To Minority Shareholders

PaymentsToMinorityShareholders

794000

usd

CY2022

us-gaap

Payments To Minority Shareholders

PaymentsToMinorityShareholders

997000

usd

CY2024

us-gaap

Proceeds From Minority Shareholders

ProceedsFromMinorityShareholders

2994000

usd

CY2023

us-gaap

Proceeds From Minority Shareholders

ProceedsFromMinorityShareholders

0

usd

CY2022

us-gaap

Proceeds From Minority Shareholders

ProceedsFromMinorityShareholders

3672000

usd

CY2024

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

10472000

usd

CY2023

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

1828000

usd

CY2022

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

10071000

usd

CY2024

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-85186000

usd

CY2023

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-498718000

usd

CY2022

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

115830000

usd

CY2024

us-gaap

Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

-2064000

usd

CY2023

us-gaap

Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

-14862000

usd

CY2022

us-gaap

Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

-6293000

usd

CY2024

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-1337000

usd

CY2023

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-139963000

usd

CY2022

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

127789000

usd

CY2023Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

208357000

usd

CY2022Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

348320000

usd

CY2021Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

220531000

usd

CY2024Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

207020000

usd

CY2023Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

208357000

usd

CY2022Q1

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

348320000

usd

CY2021Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

3891468000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

242870000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest

148565000

usd

CY2022

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

55777000

usd

CY2022

us-gaap

Stock Issued During Period Value Employee Stock Purchase Plan

StockIssuedDuringPeriodValueEmployeeStockPurchasePlan

67499000

usd

CY2022

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.69

CY2022

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

163169000

usd

CY2022

us-gaap

Stock Issued During Period Value Acquisitions

StockIssuedDuringPeriodValueAcquisitions

2689317000

usd

CY2022

ste

Consideration Related To Equity Component Of Cantel Convertible Debt

ConsiderationRelatedToEquityComponentOfCantelConvertibleDebt

175555000

usd

CY2022

ste

Consideration Related To Cantel Equity Compensation Programs

ConsiderationRelatedToCantelEquityCompensationPrograms

18173000

usd

CY2022

ste

Reclassification To Cantel Convertible Debt Premium Liability

ReclassificationToCantelConvertibleDebtPremiumLiability

175555000

usd

CY2022

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

997000

usd

CY2022

ste

Noncontrolling Interest Increase From Contributions To Noncontrolling Interest Holders

NoncontrollingInterestIncreaseFromContributionsToNoncontrollingInterestHolders

3672000

usd

CY2022

ste

Increase Decrease In Noncontrolling Interests Other

IncreaseDecreaseInNoncontrollingInterestsOther

-146000

usd

CY2022Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

6544637000

usd

CY2023

us-gaap

Profit Loss

ProfitLoss

105813000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest

110902000

usd

CY2023

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

308565000

usd

CY2023

us-gaap

Stock Issued During Period Value Employee Stock Purchase Plan

StockIssuedDuringPeriodValueEmployeeStockPurchasePlan

40777000

usd

CY2023

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

183498000

usd

CY2023

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

794000

usd

CY2023

ste

Increase Decrease In Noncontrolling Interests Other

IncreaseDecreaseInNoncontrollingInterestsOther

296000

usd

CY2023Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

6087172000

usd

CY2024

us-gaap

Profit Loss

ProfitLoss

380079000

usd

CY2024

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest

7947000

usd

CY2024

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

11765000

usd

CY2024

us-gaap

Stock Issued During Period Value Employee Stock Purchase Plan

StockIssuedDuringPeriodValueEmployeeStockPurchasePlan

67009000

usd

CY2024

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

2.03

CY2024

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

200570000

usd

CY2024

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

1562000

usd

CY2024

ste

Noncontrolling Interest Increase From Contributions To Noncontrolling Interest Holders

NoncontrollingInterestIncreaseFromContributionsToNoncontrollingInterestHolders

2994000

usd

CY2024

ste

Increase Decrease In Noncontrolling Interests Other

IncreaseDecreaseInNoncontrollingInterestsOther

64000

usd

CY2024Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

6315346000

usd

CY2024

us-gaap

Nature Of Operations

NatureOfOperations

<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of Operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. We offer our Customers a unique mix of innovative products and services. These include: consumable products, such as detergents, endoscopy accessories, barrier products, instruments and tools; and services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair, laboratory testing, outsourced reprocessing; and capital equipment, such as sterilizers, surgical tables, and automated endoscope reprocessors, and connectivity solutions such as operating room (“OR”) integrati</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate and report our financial information in three reportable business segments: Healthcare, Applied Sterilization Technologies ("AST"), and Life Sciences.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previously, we had four reportable business segments, however, as a result of the agreement to divest our Dental segment, Dental is presented as discontinued operations. Historical information has been retrospectively adjusted to reflect these changes for comparability purposes, as required. We describe our business segments in Note 13 titled "Business Segment Information."</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on March 31. References in this Annual Report to a particular "year," "fiscal," "fiscal year," or "year-end" mean our fiscal year. The significant accounting policies applied in preparing the accompanying consolidated financial statements of the Company are summarized below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the consolidation method to report our investment in our subsidiaries. Therefore, the accompanying consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. We eliminate intercompany accounts and transactions when we consolidate these accounts. Investments in equity of unconsolidated affiliates, over which the Company has significant influence, but not control, over the financial and operating polices, are accounted for primarily using the equity method. These investments are immaterial to the Company's consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Discontinued Operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 11, 2024, the Company announced its plan to sell substantially all of the net assets of its Dental segment for total cash consideration of $787,500, subject to customary adjustments, and up to an additional $12.5 million in contingent payment should the Dental business achieve certain revenue targets in fiscal 2025. The transaction is structured as an equity sale. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A component of an entity is reported in discontinued operations after meeting the criteria for held for sale classification if the disposition represents a strategic shift that has (or will have) a major effect on the entity's operations and financial results. We analyzed the quantitative and qualitative factors relevant to the divestiture of our Dental segment and determined that those conditions for discontinued operations presentation had been met prior to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">March 31, 2024. The Dental segment results of operations have been reclassified to income (loss) from discontinued operations in the Consolidated Statements of Income, and we have classified the Dental segment's assets and liabilities as held for sale for all periods presented in the accompanying Consolidated Balance Sheets. The transaction is anticipated to close in the first quarter of fiscal 2025. Therefore, the held for sale assets and liabilities are classified as current as of March 31, 2024. Our Consolidated Statements of Cash Flows include the financial results of the Dental segment for all periods presented. For additional information regarding this transaction and its effect on our financial reporting, refer to Note 4 titled, "Discontinued Operations" and Note 13 titled, "Business Segment Information."</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make certain estimates and assumptions when preparing financial statements according to accounting principles generally accepted in the United States ("U.S. GAAP") that affect the reported amounts of assets and liabilities at the financial statement dates and the reported amounts of revenues and expenses during the periods presented. These estimates and assumptions involve judgments with respect to many factors that are difficult to predict and are beyond our control. Actual results could be materially different from these estimates. We revise the estimates and assumptions as new information becomes available.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents and Supplemental Cash Flow Information. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are all highly liquid investments with a maturity of three months or less when purchased. We invest our excess cash in short-term instruments including money market funds, money market deposit accounts, bank savings accounts, and time deposits with major banks and financial institutions. We select investments in accordance with the criteria established in our investment policy. Our investment policy specifies, among other things, maturity, credit quality and concentration restrictions with the objective of preserving capital and maintaining adequate liquidity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information supplementing our Consolidated Statements of Cash Flows is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:55.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142,167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271,274</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,382 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received during the year for income tax refunds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,315 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,605 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition and Associated Liabilities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when obligations under the terms of the contract are satisfied and control of the promised products or services have transferred to the Customer. Revenues are measured at the amount of consideration that we expect to be paid in exchange for the products or services. Product revenue is recognized when control passes to the Customer, which is generally based on contract or shipping terms. Service revenue is recognized when the Customer benefits from the service, which occurs either upon completion of the service or as it is provided to the Customer. Our Customers include end users as well as dealers and distributors who market and sell our products. Our revenue is not contingent upon resale by the dealer or distributor, and we have no further obligations related to bringing about resale. Our standard return and restocking fee policies are applied to sales of products. Shipping and handling costs charged to Customers are included in Product revenues. The associated expenses are treated as fulfillment costs and are included in Cost of revenues. Revenues are reported net of sales and value-added taxes collected from Customers.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have individual Customer contracts that offer discounted pricing. Dealers and distributors may be offered sales incentives in the form of rebates. We reduce revenue for discounts and estimated returns, rebates, and other similar allowances in the same period the related revenues are recorded. The reduction in revenue for these items is estimated based on historical experience and trend analysis to the extent that it is probable that a significant reversal of revenue will not occur. Estimated returns are recorded gross on the Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In transactions that contain multiple performance obligations, such as when products, maintenance services, and other services are combined, we recognize revenue as each product is delivered or service is provided to the Customer. We allocate the total arrangement consideration to each performance obligation based on its relative standalone selling price, which is the price for the product or service when it is sold separately.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms vary by the type and location of the Customer and the products or services offered. Generally, the time between when revenue is recognized and when payment is due is not significant. We do not evaluate whether the selling price contains a financing component for contracts that have a duration of less than one year.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not capitalize sales commissions as substantially all of our sales commission programs have an amortization period of one year or less.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs to fulfill a contract are capitalized and amortized over the term of the contract if they are recoverable, directly related to a contract and generate resources that we will use to fulfill the contract in the future. At March 31, 2024, assets related to costs to fulfill a contract were not material to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 titled, "Business Segment Information" for disaggregation of revenue.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues consist of revenues generated from sales of consumables and capital equipment. These contracts are primarily based on a Customer’s purchase order and may include a Distributor, Dealer or Group Purchasing Organization ("GPO") agreement.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue for sales of products when control passes to the Customer, which generally occurs either when the products are shipped or when they are received by the Customer. Revenue related to capital equipment products is deferred until installation is complete if the capital equipment and installation are highly integrated and form a single performance obligation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenues</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our Healthcare and Life Sciences segments, service revenues include revenue generated from parts and labor associated with the maintenance, repair and installation of capital equipment. These contracts are primarily based on a Customer’s purchase order and may include a Distributor, Dealer, or GPO agreement. For maintenance, repair and installation of capital equipment, revenue is recognized upon completion of the service. Healthcare service revenues also include outsourced reprocessing services and instrument repairs. Contracts for outsourced reprocessing services are primarily based on an agreement with a Customer, ranging in length from several months to 15 years. Outsourced reprocessing services revenue is </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized ratably over the contract term using a time-based input measure, adjusted for volume and other performance metrics, to the extent that it is probable that a significant reversal of revenue will not occur. Contracts for instrument repairs are primarily based on a Customer’s purchase order, and the associated revenue is recognized upon completion of the repair. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer preventive maintenance and separately priced extended warranty agreements to our Customers, which require us to maintain and repair products over the duration of the contract. Generally, these contract terms are cancellable without penalty and range from one to five years. Amounts received under these Customer contracts are initially recorded as a service liability and are recognized as service revenue ratably over the contract term using a time-based input measure. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our AST segment, service revenues include contract sterilization and laboratory services. Sales contracts for contract sterilization and laboratory services are primarily based on a Customer’s purchase order and associated Customer agreement, and revenues are generally recognized upon completion of the service.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments received from Customers are based on invoices or billing schedules as established in contracts with Customers. Deferred revenue is recorded when payment is received in advance of performance under the contract. Deferred revenue is recognized as revenue upon completion of the performance obligation, which generally occurs within one year. During fiscal 2024, we recognized revenue of $66,690 that was included in our contract liability balance at the beginning of the period. During fiscal 2023, we recognized revenue of $72,914 that was included in our contract liability balance at the beginning of the period.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9 titled, "Additional Consolidated Balance Sheet Information" for deferred revenue balances.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Liabilities</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments received in advance of performance for cancellable preventive maintenance and separately priced extended warranty contracts are recorded as service liabilities. Service liabilities are recognized as revenue as performance is rendered under the contract. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9 titled, "Additional Consolidated Balance Sheet Information" for service liability balances.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations reflect only the performance obligations related to agreements for which we have a firm commitment from a Customer to purchase, and exclude variable consideration related to unsatisfied performance obligations. With regard to products, these remaining performance obligations include orders for capital equipment and consumables where control of the products has not passed to the customer. With regard</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to service, these remaining performance obligations primarily include installation, certification, and outsourced reprocessing services. As of March 31, 2024, the transaction price allocated to remaining performance obligations was approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,419,646</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We expect to recognize approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the transaction price within one year and approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> beyond one year. The remainder has yet to be scheduled for delivery.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Accounts receivable are presented at their face amount, less allowances for sales returns and uncollectible accounts. Accounts receivable consist of amounts billed and currently due from Customers and amounts earned but unbilled. We may obtain and perfect a security interest in products sold in the United States when we have a concern with the Customer's risk profile.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for uncollectible accounts receivable for estimated losses in the collection of amounts owed by Customers. We estimate the allowance based on analyzing a number of factors, including amounts written off historically, Customer payment practices, and general economic conditions. We also analyze significant Customer accounts on a regular basis and record a specific allowance when we become aware of a specific Customer’s inability to pay. As a result, the related accounts receivable are reduced to an amount that we reasonably believe is collectible.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for sales returns based upon known returns and estimated returns for both capital equipment and consumables. We estimate returns of capital equipment and consumables based upon recent historical experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> net. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of their cost and net realizable value determined by the first-in, first-out cost method. Inventory costs include material, labor, and overhead.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review inventory on an ongoing basis, considering factors such as deterioration, obsolescence, and other items. We record an allowance for estimated losses when the facts and circumstances indicate that particular inventories will not be usable. If future market conditions vary from those projected, and our estimates prove to be inaccurate, we may be required to write-down inventory values and record an adjustment to Cost of revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant, and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our property, plant, and equipment consists of land and land improvements, buildings and leasehold improvements, machinery and equipment, information systems, radioisotope (cobalt-60), and construction in progress. Property, plant, and equipment are presented at cost less accumulated depreciation and depletion. We capitalize additions and improvements. Repairs and maintenance are charged to expense as they are incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land is not depreciated and construction in progress is not depreciated until placed in service. Depreciation of most assets is computed on the cost less the estimated salvage value by using the straight-line method over the estimated remaining useful lives. Depletion of radioisotope is computed using the annual decay factor of the material, which is similar to the sum-of-the-years-digits method.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally depreciate or deplete property, plant, and equipment over the useful lives presented in the following table:</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful Life<br/>(years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-40</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-50</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-20</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information Systems</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-20</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radioisotope (cobalt-60)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we sell, retire, or dispose of property, plant, and equipment, we remove the asset’s cost and accumulated depreciation from our Consolidated Balance Sheet. We recognize the net gain or loss on the sale or disposition in the Consolidated Statements of Income in the period when the transaction occurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize interest costs incurred during the construction of long-lived assets. We capitalized interest costs of $7,094 and $6,366 for the years ended March 31, 2024 and 2023, respectively. Total interest expense for the years ended March 31, 2024, 2023, and 2022 was $144,351, $107,956, and $89,490, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Identifiable Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our identifiable intangible assets include product technology rights, trademarks, licenses, non-compete agreements, and Customer and vendor relationships. We record these assets at cost, or when acquired as part of a business acquisition, at estimated fair value. Determining the fair value of identifiable intangible assets requires management’s judgment and often involves the use of significant estimates and assumptions, including assumptions with respect to forecasted revenue growth rates, forecasted profit margins, and Customer attrition rates, among other items. We generally amortize identifiable intangible assets over periods ranging from 5 to 20 years using the straight-line method. Our intangible assets also include indefinite lived assets including certain trademarks and tradenames that were acquired in connection with business combinations. These assets are tested at least annually for impairment. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in marketable securities are stated at fair value and are included in Other assets on the Consolidated Balance Sheets. Changes in the fair value of these investments are recorded in the Interest and miscellaneous (income) expense line of the Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Impairment Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant, equipment, and identifiable intangible assets are reviewed for impairment when indicators of impairment exist and circumstances indicate that the carrying value of such assets may not be recoverable. Impaired assets are recorded at the lower of carrying value or estimated fair value. We monitor for such indicators on an ongoing basis and if an impairment exists, we record the loss in the Consolidated Statements of Income during that period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Retirement Obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We incur retirement obligations for certain assets. We record initial liabilities for the asset retirement obligations ("ARO") at fair value. Recognition of ARO includes estimating the present value of a liability and offsetting asset, the subsequent accretion of that liability and depletion of the asset, and a periodic review of the ARO liability estimates and discount rates used in the analysis. We provide additional information about our asset retirement obligations in Note 7 titled, “Property, Plant, and Equipment.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions of Business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets acquired and liabilities assumed in a business combination are accounted for at fair value on the date of acquisition. Costs related to the acquisition are expensed as incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We perform our annual impairment test for goodwill in the third quarter of each year. We may consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill. We may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. We review the book value compared to the fair value at the reporting unit level. We calculate the fair value of our reporting units based on the present value of estimated future cash flows. Management's judgment is necessary to evaluate the impact of operating and macroeconomic changes and to estimate future cash flows to measure fair value. Assumptions used in our impairment evaluations, such as forecasted growth rates and cost of capital, are consistent with internal projections, strategic plans, and operating plans. We believe such assumptions and estimates are also comparable to those that would be used by other marketplace participants.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance Liabilities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record a liability for self-insured risks that we retain for general and product liabilities, workers’ compensation, and automobile liabilities based on actuarial calculations. We use our historical loss experience and actuarial methods to calculate the liability. This liability includes estimates for both known losses and incurred but not reported claims. We review the assumptions used to calculate the estimated liability at least annually to evaluate the adequacy of the amount recorded. We maintain insurance policies to cover losses greater than our estimated liability, which are subject to the terms and conditions of those policies. We are also self-insured for certain employee medical claims. We estimate a liability for incurred but not reported claims based upon recent claims experience. Liability amounts are recorded in the "Accrued expenses and other" and "Other liabilities" line of our Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Benefit Plans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We sponsor defined benefit pension plans. We also sponsor a post-retirement benefits plan for certain former employees. We determine our costs and obligations related to these plans by evaluating input from third-party professional advisers. These costs and obligations are affected by assumptions including the discount rate, expected long-term rate of return on plan assets, the annual rate of change in compensation for eligible employees, estimated changes in costs of healthcare benefits, and other factors. We review the assumptions used on an annual basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize an asset for the overfunded status or a liability for the underfunded status of defined benefit pension and post-retirement benefits plans in our Consolidated Balance Sheets. This amount is measured as the difference between the fair value of plan assets and the benefit obligation (the projected benefit obligation for pension plans and the accumulated post-retirement benefit obligation for other post-retirement benefit plans). Changes in the funded status of the plans are recorded in other comprehensive income in the year they occur. We measure plan assets and obligations as of the balance sheet date. We provide additional information about our pension and other post-retirement benefits plans in Note 11 titled, “Benefit Plans.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except for long-term debt, our financial instruments are highly liquid or have short-term maturities. We provide additional information about the fair value of our financial instruments in Note 19 titled, “Fair Value Measurements.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Most of our operations use their local currency as their functional currency. Financial statements of subsidiaries are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and a weighted average exchange rate for each period for revenues, expenses, gains and losses. Translation adjustments for subsidiaries whose local currency is their functional currency are recorded as a component of accumulated other comprehensive income (loss) within equity. Transaction gains and losses resulting from fluctuations in currency exchange rates on transactions denominated in currencies other than the functional currency are recognized as incurred in the accompanying Consolidated Statements of Income, except for certain intercompany balances designated as long-term in nature.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward and Swap Contracts. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We enter into foreign currency forward contracts to hedge assets and liabilities denominated in foreign currencies, including intercompany transactions. We may also enter into commodity swap contracts to hedge price changes in nickel that impact raw materials included in our Cost of revenues. We may also hold forward foreign exchange contracts to hedge a portion of our expected non-U.S. dollar denominated earnings against our reporting currency, the U.S. dollar. We do not use derivative financial instruments for speculative purposes. These contracts are marked to market, with gains and losses recognized within Selling, general, and administrative expenses or Cost of revenues in the accompanying Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranty.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Warranties are provided on the sale of certain of our products and services and an accrual for estimated future claims is recorded at the time revenue is recognized. We estimate warranty expense based primarily on historical warranty claim experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record shipping and handling costs in Cost of revenues. Shipping and handling costs charged to Customers are recorded as revenues in the period the product revenues are recognized.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs incurred for communicating, advertising and promoting our products are generally expensed when incurred as a component of Selling, general, and administrative expenses. We incurred $25,474, $21,668, and $15,599 of advertising costs during the years ended March 31, 2024, 2023, and 2022, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We incur research and development costs associated with commercial products and expense these costs as incurred. If a Customer reimburses us for research and development costs, the costs are charged to the related contracts as Cost of revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We defer income taxes for all temporary differences between pre-tax financial and taxable income and between the book and tax basis of assets and liabilities. We record valuation allowances to reduce net deferred tax assets to an amount that we expect will more-likely-than-not be realized. In making such a determination, we consider all available information, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and if applicable, any carryback claims that can be filed. In the event we were to determine that we would be able to realize our deferred income tax assets in the future in excess of their net recorded amount, we would make an adjustment to the valuation allowance which would reduce the provision for income taxes and the effective tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate uncertain tax positions in accordance with a two-step process. The first step is recognition: The determination of whether or not it is more-likely-than-not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, we presume that the position will be examined by the appropriate tax authority and that the tax authority will have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not threshold is measured to determine the amount of benefit to recognize in the financial statements. The measurement process requires the determination of the range of possible settlement amounts and the probability of achieving each of the possible settlements. The tax position is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. No tax benefits are recognized for positions that do not meet the more-likely-than-not threshold. Tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not recognition threshold are derecognized in the first subsequent financial reporting period in which the threshold is no longer met. We describe income taxes further in Note 10 titled, “Income Taxes.”</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We describe share-based compensation in Note 16 titled, “Share-Based Compensation.” We measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. We record liability awards at fair value each reporting period, and the change in fair value is reflected as share-based compensation expense in our Consolidated Statements of Income. The expense is classified as Cost of revenues, Selling, general, and administrative expenses or Research and development expenses in a manner consistent with the employee’s compensation and benefits. These costs are recognized in the Consolidated Statements of Income over the period during which an employee is required to provide service in exchange for the award. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recognize restructuring expenses associated with actions designed to enhance profitability and improve efficiency of our operations. Severance and other compensation related costs include severance, medical benefits, and other termination benefits. For ongoing benefit arrangements, a liability is recognized when it is probable that employees will be entitled to benefits and the amount can be reasonably estimated. For one-time benefit arrangements, a liability is incurred and must be accrued at the date the plan is communicated to employees, unless they will be retained beyond a minimum retention period. In this case, the liability is calculated at the date the plan is communicated to employees and is accrued ratably over the future service period. Asset impairment expenses primarily relate to adjustments in the carrying value of facilities and machinery and equipment associated with restructuring actions to their estimated fair value. In addition, the remaining useful lives of other property, plant, and equipment associated with the restructuring actions are re-evaluated, which may result in the acceleration of depreciation and amortization of certain assets. Other restructuring expenses are expensed as incurred. Product rationalization charges relate to inventory write-downs and are recognized in Cost of revenues in the Consolidated Statements of Income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our recent restructurings, refer to Note 2 titled, "Restructuring." </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Impacting the Company </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently Issued Accounting Standards Impacting the Company are presented in the following table:</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:14.136%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.331%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.609%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Issuance</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Adoption</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect on the financial statements or other significant matters</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standards that have been adopted in fiscal 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2022-04 "Liabilities - Supplier Finance Programs (Subtopic 405-50) Disclosure of Supplier Finance Program Obligations."</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The standard provides guidance to enhance the transparency of disclosures for entities that utilize supplier finance programs to include information about the key terms of the programs and present a rollforward of any obligations under the program where those obligations are presented in the balance sheet.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We adopted this standard in fiscal 2024 with no material impact to our consolidated financial statements.</span></div></td></tr><tr><td colspan="27" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standards that have not yet been adopted.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2023-07 "Segment Reporting (Topic 280)<br/>Improvements to Reportable Segment Disclosures."</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The standard provides guidance to enhance disclosures related to reportable segment expenses, including requirements to disclose significant segment expenses that are regularly provided to the Chief Operating Decision Maker ("CODM"), the title and position of the CODM and a description of how the CODM uses the information to make decisions regarding the allocation of resources. The standard also requires disclosure of certain segment information currently required annually to be reported on an interim basis. The amendments in this standard are effective for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024.</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are currently assessing the impact of this standard update on our disclosures in the notes to the consolidated financial statements.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2023-09 "Income Taxes (Topic 740) Improvements to Income Tax Disclosures."</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The standard provides guidance to enhance disclosures related to income taxes paid (net of refunds), requiring disaggregation by federal, state, and foreign, and disclosure of income taxes paid (net of refunds received) by individual jurisdictions that represent greater than 5% of the total. The standard also requires disclosure of income (loss) from continuing operations before income taxes, disaggregated between domestic and foreign, and income tax expense (or benefit) disaggregated by federal, state, and foreign. Finally, the standard removes the requirement for certain disclosures related to changes in unrecognized tax benefits and certain amounts of temporary differences. The amendments in this standard are effective for annual periods beginning after December 15, 2024.</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are currently assessing the impact of this standard update on our disclosures in the notes to the consolidated financial statements.</span></div></td></tr></table></div>

CY2024

us-gaap

Use Of Estimates

UseOfEstimates

<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make certain estimates and assumptions when preparing financial statements according to accounting principles generally accepted in the United States ("U.S. GAAP") that affect the reported amounts of assets and liabilities at the financial statement dates and the reported amounts of revenues and expenses during the periods presented. These estimates and assumptions involve judgments with respect to many factors that are difficult to predict and are beyond our control. Actual results could be materially different from these estimates. We revise the estimates and assumptions as new information becomes available.</span></div>

CY2024

us-gaap

Interest Paid

InterestPaid

142167000

usd

CY2023

us-gaap

Interest Paid

InterestPaid

108470000

usd

CY2022

us-gaap

Interest Paid

InterestPaid

84696000

usd

CY2024

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

271274000

usd

CY2023

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

254661000

usd

CY2022

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

138382000

usd

CY2024

us-gaap

Proceeds From Income Tax Refunds

ProceedsFromIncomeTaxRefunds

19175000

usd

CY2023

us-gaap

Proceeds From Income Tax Refunds

ProceedsFromIncomeTaxRefunds

2315000

usd

CY2022

us-gaap

Proceeds From Income Tax Refunds

ProceedsFromIncomeTaxRefunds

4605000

usd

CY2024

us-gaap

Deferred Revenue Revenue Recognized1

DeferredRevenueRevenueRecognized1

66690000

usd

CY2023

us-gaap

Deferred Revenue Revenue Recognized1

DeferredRevenueRevenueRecognized1

72914000

usd

CY2024Q1

us-gaap

Revenue Remaining Performance Obligation

RevenueRemainingPerformanceObligation

1419646000

usd

CY2024

us-gaap

Interest Costs Capitalized

InterestCostsCapitalized

7094000

usd

CY2023

us-gaap

Interest Costs Capitalized

InterestCostsCapitalized

6366000

usd

CY2024

us-gaap

Interest Costs Incurred

InterestCostsIncurred

144351000

usd

CY2023

us-gaap

Interest Costs Incurred

InterestCostsIncurred

107956000

usd

CY2022

us-gaap

Interest Costs Incurred

InterestCostsIncurred

89490000

usd

CY2024

us-gaap

Property Plant And Equipment Impairment

PropertyPlantAndEquipmentImpairment

<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Impairment Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant, equipment, and identifiable intangible assets are reviewed for impairment when indicators of impairment exist and circumstances indicate that the carrying value of such assets may not be recoverable. Impaired assets are recorded at the lower of carrying value or estimated fair value. We monitor for such indicators on an ongoing basis and if an impairment exists, we record the loss in the Consolidated Statements of Income during that period.</span></div>

CY2024

us-gaap

Advertising Expense

AdvertisingExpense

25474000

usd

CY2023

us-gaap

Advertising Expense

AdvertisingExpense

21668000

usd

CY2022

us-gaap

Advertising Expense

AdvertisingExpense

15599000

usd

CY2024

us-gaap

Restructuring And Related Cost Expected Number Of Positions Eliminated

RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated

300

unit

CY2024

ste

Asset Acquisition Tax Deductible Goodwill Expected

AssetAcquisitionTaxDeductibleGoodwillExpected

60000000

usd

CY2022Q1

dei

Entity Number Of Employees

EntityNumberOfEmployees

3700

CY2022Q1

ste

Cantel Acquisition Assumed Debt Obligations

CantelAcquisitionAssumedDebtObligations

721284000

usd

CY2022Q1

ste

Deferred Consideration

DeferredConsideration

50000

usd

CY2024Q1

us-gaap

Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount

BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount

195667000

usd

CY2023Q1

us-gaap

Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount

BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount

4863000

usd

CY2022Q1

us-gaap

Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount

BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount

427035000

usd

CY2024

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

25526000

usd

CY2023

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

23486000

usd

CY2022

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

201905000

usd

CY2024

ste

Loss On Classification As Held For Sale

LossOnClassificationAsHeldForSale

206444000

usd

CY2023

ste

Loss On Classification As Held For Sale

LossOnClassificationAsHeldForSale

0

usd

CY2022

ste

Loss On Classification As Held For Sale

LossOnClassificationAsHeldForSale

0

usd

CY2023

us-gaap

Goodwill Impairment Loss

GoodwillImpairmentLoss

490565000

usd

CY2024

us-gaap

Effective Income Tax Rate Reconciliation Disposition Of Business

EffectiveIncomeTaxRateReconciliationDispositionOfBusiness

0.243

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Disposition Of Business

EffectiveIncomeTaxRateReconciliationDispositionOfBusiness

0.139

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Disposition Of Business

EffectiveIncomeTaxRateReconciliationDispositionOfBusiness

0.205

CY2023

ste

Non Deductible Goodwill Impairment

NonDeductibleGoodwillImpairment

207367000

usd

CY2022Q1

us-gaap

Goodwill

3938976000

usd

CY2023

us-gaap

Goodwill Acquired During Period

GoodwillAcquiredDuringPeriod

7024000

usd

CY2023

us-gaap

Goodwill Purchase Accounting Adjustments

GoodwillPurchaseAccountingAdjustments

-18477000

usd

CY2023

ste

Goodwill Decrease From Divestitures

GoodwillDecreaseFromDivestitures

-2358000

usd

CY2023

us-gaap

Goodwill Foreign Currency Translation Gain Loss

GoodwillForeignCurrencyTranslationGainLoss

-45946000

usd

CY2023Q1

us-gaap

Goodwill

3879219000

usd

CY2024

us-gaap

Goodwill Acquired During Period

GoodwillAcquiredDuringPeriod

200086000

usd

CY2024

us-gaap

Goodwill Purchase Accounting Adjustments

GoodwillPurchaseAccountingAdjustments

-2573000

usd

CY2024

us-gaap

Goodwill Foreign Currency Translation Gain Loss

GoodwillForeignCurrencyTranslationGainLoss

-6020000

usd

CY2024Q1

us-gaap

Goodwill

4070712000

usd

CY2024Q1

us-gaap

Finite Lived Intangible Assets Gross

FiniteLivedIntangibleAssetsGross

3390779000

usd

CY2024Q1

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

1271497000

usd

CY2023Q1

us-gaap

Finite Lived Intangible Assets Gross

FiniteLivedIntangibleAssetsGross

3080820000

usd

CY2023Q1

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

1004121000

usd

CY2024Q1

us-gaap

Indefinite Lived Intangible Assets Excluding Goodwill

IndefiniteLivedIntangibleAssetsExcludingGoodwill

14250000

usd

CY2024

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

268319000

usd

CY2023

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

259676000

usd

CY2022

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

264607000

usd

CY2024Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Next Twelve Months

FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

270365000

usd

CY2024Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Two

FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

261498000

usd

CY2024Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Three

FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

255383000

usd

CY2024Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Four

FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

250617000

usd

CY2024Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Five

FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

248061000

usd

CY2024Q1

us-gaap

Inventory Raw Materials

InventoryRawMaterials

245942000

usd

CY2023Q1

us-gaap

Inventory Raw Materials

InventoryRawMaterials

220431000

usd

CY2024Q1

us-gaap

Inventory Work In Process

InventoryWorkInProcess

98304000

usd

CY2023Q1

us-gaap

Inventory Work In Process

InventoryWorkInProcess

93971000

usd

CY2024Q1

us-gaap

Inventory Finished Goods

InventoryFinishedGoods

374182000

usd

CY2023Q1

us-gaap

Inventory Finished Goods

InventoryFinishedGoods

325609000

usd

CY2024Q1

us-gaap

Inventory Valuation Reserves

InventoryValuationReserves

43893000

usd

CY2023Q1

us-gaap

Inventory Valuation Reserves

InventoryValuationReserves

35601000

usd

CY2024Q1

us-gaap

Inventory Net

InventoryNet

674535000

usd

CY2023Q1

us-gaap

Inventory Net

InventoryNet

604410000

usd

CY2024Q1

us-gaap

Land

90134000

usd

CY2023Q1

us-gaap

Land

77757000

usd

CY2024Q1

us-gaap

Buildings And Improvements Gross

BuildingsAndImprovementsGross

724492000

usd

CY2023Q1

us-gaap

Buildings And Improvements Gross

BuildingsAndImprovementsGross

658108000

usd

CY2024Q1

us-gaap

Machinery And Equipment Gross

MachineryAndEquipmentGross

1075082000

usd

CY2023Q1

us-gaap

Machinery And Equipment Gross

MachineryAndEquipmentGross

959952000

usd

CY2024Q1

ste

Computer Softwareand Hardwaregross

ComputerSoftwareandHardwaregross

256671000

usd

CY2023Q1

ste

Computer Softwareand Hardwaregross

ComputerSoftwareandHardwaregross

240933000

usd

CY2024Q1

us-gaap

Materials Supplies And Other

MaterialsSuppliesAndOther

692642000

usd

CY2023Q1

us-gaap

Materials Supplies And Other

MaterialsSuppliesAndOther

637920000

usd

CY2024Q1

us-gaap

Construction In Progress Gross

ConstructionInProgressGross

500106000

usd

CY2023Q1

us-gaap

Construction In Progress Gross

ConstructionInProgressGross

472206000

usd

CY2024Q1

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

3339127000

usd

CY2023Q1

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

3046876000

usd

CY2024Q1

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

1573947000

usd

CY2023Q1

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

1414101000

usd

CY2024Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1765180000

usd

CY2023Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1632775000

usd

CY2024

us-gaap

Depreciation

181722000

usd

CY2023

us-gaap

Depreciation

165019000

usd

CY2022

us-gaap

Depreciation

176298000

usd

CY2022Q1

us-gaap

Asset Retirement Obligation

AssetRetirementObligation

13543000

usd

CY2023

us-gaap

Asset Retirement Obligation Liabilities Incurred

AssetRetirementObligationLiabilitiesIncurred

86000

usd

CY2023

us-gaap

Asset Retirement Obligation Liabilities Settled

AssetRetirementObligationLiabilitiesSettled

625000

usd

CY2023

us-gaap

Asset Retirement Obligation Accretion Expense

AssetRetirementObligationAccretionExpense

104000

usd

CY2023

us-gaap

Asset Retirement Obligation Foreign Currency Translation Gain Loss

AssetRetirementObligationForeignCurrencyTranslationGainLoss

23000

usd

CY2023Q1

us-gaap

Asset Retirement Obligation

AssetRetirementObligation

13131000

usd

CY2024

us-gaap

Asset Retirement Obligation Liabilities Incurred

AssetRetirementObligationLiabilitiesIncurred

253000

usd

CY2024

us-gaap

Asset Retirement Obligation Liabilities Settled

AssetRetirementObligationLiabilitiesSettled

144000

usd

CY2024

us-gaap

Asset Retirement Obligation Accretion Expense

AssetRetirementObligationAccretionExpense

311000

usd

CY2024

us-gaap

Asset Retirement Obligation Foreign Currency Translation Gain Loss

AssetRetirementObligationForeignCurrencyTranslationGainLoss

107000

usd

CY2024Q1

us-gaap

Asset Retirement Obligation

AssetRetirementObligation

13658000

usd

CY2024Q1

ste

Term Loan Current Portion

TermLoanCurrentPortion

41250000

usd

CY2023Q1

ste

Term Loan Current Portion

TermLoanCurrentPortion

27500000

usd

CY2024Q1

ste

Delayed Draw Term Loan Current Portion

DelayedDrawTermLoanCurrentPortion

44688000

usd

CY2023Q1

ste

Delayed Draw Term Loan Current Portion

DelayedDrawTermLoanCurrentPortion

32500000

usd

CY2024Q1

us-gaap

Short Term Borrowings

ShortTermBorrowings

85938000

usd

CY2023Q1

us-gaap

Short Term Borrowings

ShortTermBorrowings

60000000

usd

CY2024Q1

us-gaap

Line Of Credit

LineOfCredit

484529000

usd

CY2023Q1

us-gaap

Line Of Credit

LineOfCredit

301672000

usd

CY2024Q1

us-gaap

Deferred Finance Costs Net

DeferredFinanceCostsNet

17988000

usd

CY2023Q1

us-gaap

Deferred Finance Costs Net

DeferredFinanceCostsNet

21444000

usd

CY2024Q1

ste

Term Loan Long Term Portion

TermLoanLongTermPortion

3750000

usd

CY2023Q1

ste

Term Loan Long Term Portion

TermLoanLongTermPortion

45000000

usd

CY2024Q1

ste

Delayed Draw Term Loan Long Term Portion

DelayedDrawTermLoanLongTermPortion

548438000

usd

CY2023Q1

ste

Delayed Draw Term Loan Long Term Portion

DelayedDrawTermLoanLongTermPortion

593125000

usd

CY2024Q1

us-gaap

Long Term Debt

LongTermDebt

3120162000

usd

CY2023Q1

us-gaap

Long Term Debt

LongTermDebt

3018655000

usd

CY2024Q1

us-gaap

Debt Longterm And Shortterm Combined Amount

DebtLongtermAndShorttermCombinedAmount

3206100000

usd

CY2023Q1

us-gaap

Debt Longterm And Shortterm Combined Amount

DebtLongtermAndShorttermCombinedAmount

3078655000

usd

CY2024Q1

us-gaap

Line Of Credit

LineOfCredit

484529000

usd

CY2021Q2

ste

Delayed Draw Term Loan Long Term Portion

DelayedDrawTermLoanLongTermPortion

650000000

usd

CY2021Q2

ste

Debt Instrument Convertible Units Of Property Reference

DebtInstrumentConvertibleUnitsOfPropertyReference

25.0843

CY2021Q2

ste

Debt Instrument Convertible Parent Shares

DebtInstrumentConvertibleParentShares

8.4752

shares

CY2021Q2

ste

Debt Instrument Convertible Cash Per One Thousand Dollars Ratio

DebtInstrumentConvertibleCashPerOneThousandDollarsRatio

424.68

CY2021Q2

ste

Debt Instrument Convertible Increase In Conversion Rate Shares

DebtInstrumentConvertibleIncreaseInConversionRateShares

0.9931

shares

CY2021Q2

ste

Debt Instrument Convertible Stock Price

DebtInstrumentConvertibleStockPrice

81.3520

CY2022

ste

Consideration Related To Equity Component Of Convertible Debt

ConsiderationRelatedToEquityComponentOfConvertibleDebt

175555000

usd

CY2024Q1

ste

Convertible Debt Premium Liability

ConvertibleDebtPremiumLiability

203361000

usd

CY2024Q1

us-gaap

Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months

LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths

165938000

usd

CY2024Q1

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Two

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo

662029000

usd

CY2024Q1

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Three

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

614396000

usd

CY2024Q1

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Four

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

150000000

usd

CY2024Q1

us-gaap

Long Term Debt Maturities Repayments Of Principal After Year Five

LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive

1631725000

usd

CY2024Q1

ste

Long Term Debt Excluding Deferred Financing Fees

LongTermDebtExcludingDeferredFinancingFees

3224088000

usd

CY2024Q1

us-gaap

Employee Related Liabilities Current And Noncurrent

EmployeeRelatedLiabilitiesCurrentAndNoncurrent

48152000

usd

CY2023Q1

us-gaap

Employee Related Liabilities Current And Noncurrent

EmployeeRelatedLiabilitiesCurrentAndNoncurrent

43960000

usd

CY2024Q1

us-gaap

Accrued Vacation Current And Noncurrent

AccruedVacationCurrentAndNoncurrent

16140000

usd

CY2023Q1

us-gaap

Accrued Vacation Current And Noncurrent

AccruedVacationCurrentAndNoncurrent

13348000

usd

CY2024Q1

us-gaap

Accrued Bonuses Current And Noncurrent

AccruedBonusesCurrentAndNoncurrent

61669000

usd

CY2023Q1

us-gaap

Accrued Bonuses Current And Noncurrent

AccruedBonusesCurrentAndNoncurrent

31096000

usd

CY2024Q1

us-gaap

Accrued Liabilities For Commissions Expense And Taxes

AccruedLiabilitiesForCommissionsExpenseAndTaxes

35980000

usd

CY2023Q1

us-gaap

Accrued Liabilities For Commissions Expense And Taxes

AccruedLiabilitiesForCommissionsExpenseAndTaxes

26924000

usd

CY2024Q1

us-gaap

Other Postretirement Benefits Payable Current And Noncurrent

OtherPostretirementBenefitsPayableCurrentAndNoncurrent

994000

usd

CY2023Q1

us-gaap

Other Postretirement Benefits Payable Current And Noncurrent

OtherPostretirementBenefitsPayableCurrentAndNoncurrent

1121000

usd

CY2024Q1

us-gaap

Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent

PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent

1896000

usd

CY2023Q1

us-gaap

Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent

PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent

2014000

usd

CY2024Q1

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

164831000

usd

CY2023Q1

us-gaap

Employee Related Liabilities Current

EmployeeRelatedLiabilitiesCurrent

118463000

usd

CY2024Q1

us-gaap

Deferred Revenue

DeferredRevenue

70460000

usd

CY2023Q1

us-gaap

Deferred Revenue

DeferredRevenue

85727000

usd

CY2024Q1

ste

Serviceliabilities

92590000

usd

CY2023Q1

ste

Serviceliabilities

72033000

usd

CY2024Q1

us-gaap

Self Insurance Reserve Current

SelfInsuranceReserveCurrent

13303000

usd

CY2023Q1

us-gaap

Self Insurance Reserve Current

SelfInsuranceReserveCurrent

11325000

usd

CY2024Q1

ste

Accrued Dealerand Distributor Commissions

AccruedDealerandDistributorCommissions

33277000

usd

CY2023Q1

ste

Accrued Dealerand Distributor Commissions

AccruedDealerandDistributorCommissions

27078000

usd

CY2024Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

15388000

usd

CY2023Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

13394000

usd

CY2024Q1

us-gaap

Asset Retirement Obligation Current

AssetRetirementObligationCurrent

510000

usd

CY2023Q1

us-gaap

Asset Retirement Obligation Current

AssetRetirementObligationCurrent

543000

usd

CY2024Q1

ste

Accrued Interest

AccruedInterest

11109000

usd

CY2023Q1

ste

Accrued Interest

AccruedInterest

9243000

usd

CY2024Q1

us-gaap

Other Accrued Liabilities Current And Noncurrent

OtherAccruedLiabilitiesCurrentAndNoncurrent

83107000

usd

CY2023Q1

us-gaap

Other Accrued Liabilities Current And Noncurrent

OtherAccruedLiabilitiesCurrentAndNoncurrent

78689000

usd

CY2024Q1

us-gaap

Accrued Liabilities Current And Noncurrent

AccruedLiabilitiesCurrentAndNoncurrent

319744000

usd

CY2023Q1

us-gaap

Accrued Liabilities Current And Noncurrent

AccruedLiabilitiesCurrentAndNoncurrent

298032000

usd

CY2024Q1

us-gaap

Self Insurance Reserve Noncurrent

SelfInsuranceReserveNoncurrent

21646000

usd

CY2023Q1

us-gaap

Self Insurance Reserve Noncurrent

SelfInsuranceReserveNoncurrent

22171000

usd

CY2024Q1

us-gaap

Other Postretirement Benefits Payable Noncurrent

OtherPostretirementBenefitsPayableNoncurrent

5159000

usd

CY2023Q1

us-gaap

Other Postretirement Benefits Payable Noncurrent

OtherPostretirementBenefitsPayableNoncurrent

6070000

usd

CY2024Q1

us-gaap

Defined Benefit Pension Plan Liabilities Noncurrent

DefinedBenefitPensionPlanLiabilitiesNoncurrent

2727000

usd

CY2023Q1

us-gaap

Defined Benefit Pension Plan Liabilities Noncurrent

DefinedBenefitPensionPlanLiabilitiesNoncurrent

2876000

usd

CY2024Q1

us-gaap

Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent

PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent

1321000

usd

CY2023Q1

us-gaap

Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent

PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent

1153000

usd

CY2024Q1

us-gaap

Accrued Income Taxes Noncurrent

AccruedIncomeTaxesNoncurrent

6508000

usd

CY2023Q1

us-gaap

Accrued Income Taxes Noncurrent

AccruedIncomeTaxesNoncurrent

10082000

usd

CY2024Q1

us-gaap

Asset Retirement Obligations Noncurrent

AssetRetirementObligationsNoncurrent

13148000

usd

CY2023Q1

us-gaap

Asset Retirement Obligations Noncurrent

AssetRetirementObligationsNoncurrent

12588000

usd

CY2024Q1

us-gaap

Other Liabilities

OtherLiabilities

21037000

usd

CY2023Q1

us-gaap

Other Liabilities

OtherLiabilities

21197000

usd

CY2024Q1

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

71546000

usd

CY2023Q1

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

76137000

usd

CY2024

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.125

CY2023

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.125

CY2022

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.125

CY2024

ste

Effective Tax Rate Reconciliation Increasedecreaseforuncertaintaxpositions

EffectiveTaxRateReconciliationIncreasedecreaseforuncertaintaxpositions

0

CY2023

ste

Effective Tax Rate Reconciliation Increasedecreaseforuncertaintaxpositions

EffectiveTaxRateReconciliationIncreasedecreaseforuncertaintaxpositions

0

CY2022

ste

Effective Tax Rate Reconciliation Increasedecreaseforuncertaintaxpositions

EffectiveTaxRateReconciliationIncreasedecreaseforuncertaintaxpositions

0.001

CY2024

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.022

CY2023

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

-0.011

CY2022

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.016

CY2024

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0.009

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0.007

CY2024

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Research

EffectiveIncomeTaxRateReconciliationTaxCreditsResearch

0.007

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Research

EffectiveIncomeTaxRateReconciliationTaxCreditsResearch

0.004

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Research

EffectiveIncomeTaxRateReconciliationTaxCreditsResearch

0.007

CY2024

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Foreign

EffectiveIncomeTaxRateReconciliationTaxCreditsForeign

0.009

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Foreign

EffectiveIncomeTaxRateReconciliationTaxCreditsForeign

0.008

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Tax Credits Foreign

EffectiveIncomeTaxRateReconciliationTaxCreditsForeign

0.018

CY2024

us-gaap

Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential

EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential

0.085

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential

EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential

0.089

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential

EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential

0.142

CY2024

us-gaap

Effective Income Tax Rate Reconciliation Tax Settlements

EffectiveIncomeTaxRateReconciliationTaxSettlements

0.001

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Tax Settlements

EffectiveIncomeTaxRateReconciliationTaxSettlements

0

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Tax Settlements

EffectiveIncomeTaxRateReconciliationTaxSettlements

0

CY2024

us-gaap

Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent

EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent

-0.007

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent

EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent

-0.006

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent

EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent

-0.043

CY2024

ste

Effective Tax Reconciliationdeferredtaxassetsandliabilities

EffectiveTaxReconciliationdeferredtaxassetsandliabilities

-0.003

CY2023

ste

Effective Tax Reconciliationdeferredtaxassetsandliabilities

EffectiveTaxReconciliationdeferredtaxassetsandliabilities

0

CY2022

ste

Effective Tax Reconciliationdeferredtaxassetsandliabilities

EffectiveTaxReconciliationdeferredtaxassetsandliabilities

0

CY2024

ste

U.S.Taxreformimpact Gilt Iand Fdii

U.S.taxreformimpactGILTIandFDII

-0.002

CY2023

ste

U.S.Taxreformimpact Gilt Iand Fdii

U.S.taxreformimpactGILTIandFDII

-0.003

CY2022

ste

U.S.Taxreformimpact Gilt Iand Fdii

U.S.taxreformimpactGILTIandFDII

-0.008

CY2024

ste

Capitalized Interest Costs Effectivetaxrate

CapitalizedInterestCostsEffectivetaxrate

0

CY2023

ste

Capitalized Interest Costs Effectivetaxrate

CapitalizedInterestCostsEffectivetaxrate

0

CY2022

ste

Capitalized Interest Costs Effectivetaxrate

CapitalizedInterestCostsEffectivetaxrate

0.015

CY2024

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.001

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.006

CY2024

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.213

CY2023

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.182

CY2022

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.224

CY2023

ste

Effective Income Tax Rate Reconciliation Tax Expense Benefit Changes In State And Local Tax Rates Applied

EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitChangesInStateAndLocalTaxRatesApplied

23389000

usd

CY2022

ste

Fair Value Adjustment Related To Convertible Debt Liability

FairValueAdjustmentRelatedToConvertibleDebtLiability

27806000

usd

CY2023Q1

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

2230000

usd

CY2022Q1

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

2160000

usd

CY2024

us-gaap

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

0

usd

CY2022

ste

Business Combination Non Deductible Costs

BusinessCombinationNonDeductibleCosts

67000000

usd

CY2024

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

702810000

usd

CY2023

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

680266000

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

366803000

usd

CY2024

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

26230000

usd

CY2023

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

31073000

usd

CY2022

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

20925000

usd

CY2024

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

7639000

usd

CY2023

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

8837000

usd

CY2022

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

12002000

usd

CY2024

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

218650000

usd

CY2023

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

228125000

usd

CY2022

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

168619000

usd

CY2024

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-11222000

usd

CY2023

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-43843000

usd

CY2022

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-15108000

usd

CY2024

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-923000

usd

CY2023

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-864000

usd

CY2022

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-739000

usd

CY2024

us-gaap

Increase Decrease In Deferred Income Taxes

IncreaseDecreaseInDeferredIncomeTaxes

-69120000

usd

CY2023

us-gaap

Increase Decrease In Deferred Income Taxes

IncreaseDecreaseInDeferredIncomeTaxes

-104056000

usd

CY2022

us-gaap

Increase Decrease In Deferred Income Taxes

IncreaseDecreaseInDeferredIncomeTaxes

-86275000

usd

CY2024

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

149530000

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

124069000

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

82344000

usd

CY2023

us-gaap

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

70000

usd

CY2024

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions

80000

usd

CY2023

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions

0

usd

CY2024Q1

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

2150000

usd

CY2023Q1

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

2230000

usd

CY2024Q1

us-gaap

Income Tax Examination Penalties And Interest Accrued

IncomeTaxExaminationPenaltiesAndInterestAccrued

143000

usd

CY2023Q1

us-gaap

Income Tax Examination Penalties And Interest Accrued

IncomeTaxExaminationPenaltiesAndInterestAccrued

140000

usd

CY2024Q1

us-gaap

Unrecognized Tax Benefits That Would Impact Effective Tax Rate

UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate

2293000

usd

CY2024

us-gaap

Income Tax Examination Estimate Of Possible Loss

IncomeTaxExaminationEstimateOfPossibleLoss

12000000

usd

CY2024Q1

ste

Uncertain Tax Liability Resulting From Irs Notice

UncertainTaxLiabilityResultingFromIRSNotice

50000000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits

1480000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits

1737000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits

19582000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits

15858000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

37096000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

37667000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities

13667000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities

13150000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance

2817000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance

2268000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Deferred Income

DeferredTaxAssetsDeferredIncome

20393000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Deferred Income

DeferredTaxAssetsDeferredIncome

23967000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts

3868000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts

3763000

usd

CY2024Q1

us-gaap

Deferred Tax Assets In Process Research And Development

DeferredTaxAssetsInProcessResearchAndDevelopment

28347000

usd

CY2023Q1

us-gaap

Deferred Tax Assets In Process Research And Development

DeferredTaxAssetsInProcessResearchAndDevelopment

15382000

usd

CY2024Q1

ste

Deferred Tax Assets Operatingleases

DeferredTaxAssetsOperatingleases

47625000

usd

CY2023Q1

ste

Deferred Tax Assets Operatingleases

DeferredTaxAssetsOperatingleases

46781000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Tax Credit Carryforwards Foreign

DeferredTaxAssetsTaxCreditCarryforwardsForeign

32137000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Tax Credit Carryforwards Foreign

DeferredTaxAssetsTaxCreditCarryforwardsForeign

33559000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

21258000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

11701000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

228270000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

205833000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

26374000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

20315000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

201896000

usd

CY2023Q1

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

185518000

usd

CY2024Q1

us-gaap

Deferred Tax Liabilities Property Plant And Equipment

DeferredTaxLiabilitiesPropertyPlantAndEquipment

92358000

usd

CY2023Q1

us-gaap

Deferred Tax Liabilities Property Plant And Equipment

DeferredTaxLiabilitiesPropertyPlantAndEquipment

98601000

usd

CY2024Q1

us-gaap

Deferred Tax Liabilities Leasing Arrangements

DeferredTaxLiabilitiesLeasingArrangements

46657000

usd

CY2023Q1

us-gaap

Deferred Tax Liabilities Leasing Arrangements

DeferredTaxLiabilitiesLeasingArrangements

45834000

usd

CY2024Q1

us-gaap

Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets

DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

518814000

usd

CY2023Q1

us-gaap

Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets

DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

630589000

usd

CY2024Q1

ste

Deferred Tax Liabilities Pension

DeferredTaxLiabilitiesPension

3889000

usd

CY2023Q1

ste

Deferred Tax Liabilities Pension

DeferredTaxLiabilitiesPension

2644000

usd

CY2024Q1

us-gaap

Deferred Tax Liabilities Other

DeferredTaxLiabilitiesOther

2559000

usd

CY2023Q1

us-gaap

Deferred Tax Liabilities Other

DeferredTaxLiabilitiesOther

3186000

usd

CY2024Q1

us-gaap

Deferred Income Tax Liabilities

DeferredIncomeTaxLiabilities

664277000

usd

CY2023Q1

us-gaap

Deferred Income Tax Liabilities

DeferredIncomeTaxLiabilities

780854000

usd

CY2024Q1

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

462381000

usd

CY2023Q1

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

595336000

usd

CY2024Q1

us-gaap

Operating Loss Carryforwards

OperatingLossCarryforwards

8026000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Operating Loss Carryforwards Foreign

DeferredTaxAssetsOperatingLossCarryforwardsForeign

128159000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

2269000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Tax Credit Carryforwards

DeferredTaxAssetsTaxCreditCarryforwards

33297000

usd

CY2024Q1

ste

Deferred Tax Asset Credit Carryforward German Branches

DeferredTaxAssetCreditCarryforwardGermanBranches

23954000

usd

CY2024Q1

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

26374000

usd

CY2024

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

6059000

usd

CY2024Q1

us-gaap

Undistributed Earnings Of Foreign Subsidiaries

UndistributedEarningsOfForeignSubsidiaries

2850000000

usd

CY2024

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax

3982000

usd

CY2024Q1

us-gaap

Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax

DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax

-584000

usd

CY2024Q1

us-gaap

Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year

DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear

0.0750

CY2023Q1

us-gaap

Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year

DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear

0.0750

CY2022Q1

us-gaap

Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year

DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear

0.0700

CY2024Q1

ste

Healthcare Prescription Drug

HealthcarePrescriptionDrug

0.0750

CY2023Q1

ste

Healthcare Prescription Drug

HealthcarePrescriptionDrug

0.0750

CY2022Q1

ste

Healthcare Prescription Drug

HealthcarePrescriptionDrug

0.0700

CY2024Q1

us-gaap

Defined Benefit Plan Ultimate Health Care Cost Trend Rate1

DefinedBenefitPlanUltimateHealthCareCostTrendRate1

0.0450

CY2023Q1

us-gaap

Defined Benefit Plan Ultimate Health Care Cost Trend Rate1

DefinedBenefitPlanUltimateHealthCareCostTrendRate1

0.0450

CY2022Q1

us-gaap

Defined Benefit Plan Ultimate Health Care Cost Trend Rate1

DefinedBenefitPlanUltimateHealthCareCostTrendRate1

0.0450

CY2022Q1

us-gaap

Other Investments

OtherInvestments

5383000

usd

CY2023

us-gaap

Defined Benefit Plan Change In Fair Value Of Plan Assets Level3 Reconciliation Period Increase Decrease

DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationPeriodIncreaseDecrease

-157000

usd

CY2023

us-gaap

Defined Benefit Plan Plan Assets Foreign Currency Translation Gain Loss

DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss

-159000

usd

CY2023Q1

us-gaap

Other Investments

OtherInvestments

5387000

usd

CY2024

us-gaap

Defined Benefit Plan Change In Fair Value Of Plan Assets Level3 Reconciliation Period Increase Decrease

DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationPeriodIncreaseDecrease

28000

usd

CY2024

us-gaap

Defined Benefit Plan Plan Assets Foreign Currency Translation Gain Loss

DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss

64000

usd

CY2024Q1

us-gaap

Other Investments

OtherInvestments

6110000

usd

CY2024

us-gaap

Defined Benefit Plan Plan Assets Prescription Drug Subsidy Receipt

DefinedBenefitPlanPlanAssetsPrescriptionDrugSubsidyReceipt

339000

usd

CY2023

us-gaap

Defined Benefit Plan Plan Assets Prescription Drug Subsidy Receipt

DefinedBenefitPlanPlanAssetsPrescriptionDrugSubsidyReceipt

477000

usd

CY2024Q1

ste

Defined Contribution Plan Fair Value Of Plan Assets

DefinedContributionPlanFairValueOfPlanAssets

1382313000

usd

CY2024Q1

ste

Steris Corporation Shares Held In Defined Contribution Plan

SterisCorporationSharesHeldInDefinedContributionPlan

446128

shares

CY2024Q1

ste

Fair Value Of Steris Corporatio Stock Held In Defined Contribution Plan

FairValueOfSterisCorporatioStockHeldInDefinedContributionPlan

97635000

usd

CY2024Q1

ste

Defined Contribution Plan Dividends Paid

DefinedContributionPlanDividendsPaid

915000

usd

CY2023Q1

ste

Defined Contribution Plan Dividends Paid

DefinedContributionPlanDividendsPaid

886000

usd

CY2022Q1

ste

Defined Contribution Plan Dividends Paid

DefinedContributionPlanDividendsPaid

852000

usd

CY2024

us-gaap

Defined Contribution Plan Employer Discretionary Contribution Amount

DefinedContributionPlanEmployerDiscretionaryContributionAmount

39600000

usd

CY2023

us-gaap

Defined Contribution Plan Employer Discretionary Contribution Amount

DefinedContributionPlanEmployerDiscretionaryContributionAmount

36564000

usd

CY2022

us-gaap

Defined Contribution Plan Employer Discretionary Contribution Amount

DefinedContributionPlanEmployerDiscretionaryContributionAmount

38600000

usd

CY2024Q1

us-gaap

Deferred Compensation Plan Assets

DeferredCompensationPlanAssets

1129000

usd

CY2023Q1

us-gaap

Deferred Compensation Plan Assets

DeferredCompensationPlanAssets

938000

usd

CY2024

us-gaap

Loss Contingency Disclosures

LossContingencyDisclosures

<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. COMMITMENTS AND CONTINGENCIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are, and will likely continue to be, involved in a number of legal proceedings, government investigations, and claims, which we believe generally arise in the course of our business, given our size, history, complexity, and the nature of our business, products, Customers, regulatory environment, and industries in which we participate. These legal proceedings, investigations and claims generally involve a variety of legal theories and allegations, including, without limitation, personal injury (e.g., slip and falls, burns, vehicle accidents), product liability or regulation (e.g., based on product operation or claimed malfunction, failure to warn, failure to meet specification, or failure to comply with regulatory requirements), product exposure (e.g., claimed exposure to chemicals, gases, asbestos, contaminants, radiation), property damage (e.g., claimed damage due to leaking equipment, fire, vehicles, chemicals), commercial claims (e.g., breach of contract, economic loss, warranty, misrepresentation), financial (e.g., taxes, reporting), employment (e.g., wrongful termination, discrimination, benefits matters), and other claims for damage and relief.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we have adequately reserved for our current litigation and claims that are probable and estimable, and further believe that the ultimate outcome of these pending lawsuits and claims will not have a material adverse effect on our consolidated financial position or results of operations taken as a whole. Due to their inherent uncertainty, however, there can be no assurance of the ultimate outcome or effect of current or future litigation, investigations, claims or other proceedings (including without limitation the matters discussed below). For certain types of claims, we presently maintain insurance coverage for personal injury and property damage and other liability coverages in amounts and with deductibles that we believe are prudent, but there can be no assurance that these coverages will be applicable or adequate to cover adverse outcomes of claims or legal proceedings against us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Civil, criminal, regulatory or other proceedings involving our products or services could possibly result in judgments, settlements or administrative or judicial decrees requiring us, among other actions, to pay damages or fines or effect recalls, or be subject to other governmental, Customer or other third party claims or remedies, which could materially affect our business, performance, prospects, value, financial condition, and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding these matters, see the risks and uncertainties described under the title "product and service related regulations and claims" in Item 1A. of this Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, STERIS is also involved in legal proceedings as a plaintiff involving contract, patent protection, and other claims asserted by us. Gains, if any, from these proceedings are recognized when they are realized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxation from United States federal, state and local, and foreign jurisdictions. Tax positions are settled primarily through the completion of audits within each individual jurisdiction or the closing of statutes of limitation. Changes in applicable tax law or other events may also require us to revise past estimates. We describe income taxes further in Note 10 to our consolidated financial statements titled, “Income Taxes” in t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">his Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024 and 2023, our commercial commitments totaled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$110,402</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $108,370, respectively. Commercial commitments include standby letters of credit, letters of credit required as security under our self-insured risk retention policies, and other potential cash outflows resulting from an event that requires payment by us. Approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$9,975</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $8,036 of the March 31, 2024 and 2023 totals, respectively, relate to letters of credit required as security under our self-ins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ured risk retention policies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, we had minimum purchase commitments with suppliers for raw material purchases totaling </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$61,941</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of March 31, 2024, we also had commitments of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$154,125</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for long term construction contracts. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease manufacturing, warehouse and office space, service facilities, vehicles, equipment and communication systems. Certain leases contain options that provide us with the ability to extend the lease term. Such options are included in the lease term when it is reasonably certain that the option will be exercised. We made an accounting policy election to not recognize lease assets or lease liabilities for leases with a lease term of twelve months or less. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an agreement contains a lease and classify our leases as operating or finance at the lease commencement date. Finance leases are generally those leases for which we will pay substantially all the underlying asset’s fair value or will use the asset for all or a major part of its economic life, including circumstances in which we will ultimately own the asset. Lease assets arising from finance leases are included in Property, plant, and equipment, net and the liabilities are included in Other liabilities. For finance leases, we recognize interest expense using the effective interest method, and we recognize amortization expense on the lease asset over the shorter of the lease term or the useful life of the asset. Our finance leases are not material as of March 31, 2024 and for the twelve-month period then ended. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. Lease assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. As most leases do not provide an implicit interest rate, we estimate an incremental borrowing rate to determine the present value of lease payments. Our estimated incremental borrowing rate reflects a secured rate based on recent debt issuances, our estimated credit rating, lease term, as well as publicly available data for instruments with similar characteristics. For operating leases, we recognize lease cost on a straight-line basis over the term of the lease. When accounting for leases, we combine payments for leased assets, related services and other components of a lease.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease expense recognized in income from continuing operations in the consolidated statements of income are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.184%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.184%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed operating lease expense </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,330</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,473 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,513 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable operating lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,441</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,581 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,032 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease expense</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,771</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,054 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,545 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.184%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.184%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46,946</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,249 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,144 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease obligations, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,668</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities at March 31, 2024 are as follows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,947</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32,598</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,094</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,662</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104,609</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">216,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,843</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177,067</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the preceding table, the future minimum annual rentals payable under noncancelable leases denominated in foreign currencies have been calculated using March 31, 2024 foreign currency exchange rates.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to operating leases is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term of operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.9 years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 years</span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate of operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>

CY2024

ste

Lettersofcreditassecurityforselfinsuranceriskandretentionpolicies

9975000

usd

CY2023

ste

Lettersofcreditassecurityforselfinsuranceriskandretentionpolicies

8036000

usd

CY2024Q1

us-gaap

Purchase Commitment Remaining Minimum Amount Committed

PurchaseCommitmentRemainingMinimumAmountCommitted

61941000

usd

CY2024

ste

Fixed Operating Lease Expense

FixedOperatingLeaseExpense

41330000

usd

CY2023

ste

Fixed Operating Lease Expense

FixedOperatingLeaseExpense

39473000

usd

CY2022

ste

Fixed Operating Lease Expense

FixedOperatingLeaseExpense

40513000

usd

CY2024

ste

Variable Operating Lease Expense

VariableOperatingLeaseExpense

24441000

usd

CY2023

ste

Variable Operating Lease Expense

VariableOperatingLeaseExpense

18581000

usd

CY2022

ste

Variable Operating Lease Expense

VariableOperatingLeaseExpense

12032000

usd

CY2024

us-gaap

Operating Lease Expense

OperatingLeaseExpense

65771000

usd

CY2023

us-gaap

Operating Lease Expense

OperatingLeaseExpense

58054000

usd

CY2022

us-gaap

Operating Lease Expense

OperatingLeaseExpense

52545000

usd

CY2024

us-gaap

Operating Lease Payments

OperatingLeasePayments

46946000

usd

CY2023

us-gaap

Operating Lease Payments

OperatingLeasePayments

45249000

usd

CY2022

us-gaap

Operating Lease Payments

OperatingLeasePayments

45144000

usd

CY2024

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

24668000

usd

CY2023

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

53099000

usd

CY2022

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

79241000

usd

CY2024Q1

us-gaap

Lessee Operating Lease Liability Payments Due Next Twelve Months

LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

37947000

usd

CY2024Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Two

LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

32598000

usd

CY2024Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Three

LesseeOperatingLeaseLiabilityPaymentsDueYearThree

23094000

usd

CY2024Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Four

LesseeOperatingLeaseLiabilityPaymentsDueYearFour

18662000

usd

CY2024Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Five

LesseeOperatingLeaseLiabilityPaymentsDueYearFive

104609000

usd

CY2024Q1

us-gaap

Lessee Operating Lease Liability Payments Due

LesseeOperatingLeaseLiabilityPaymentsDue

216910000

usd

CY2024Q1

us-gaap

Lessee Operating Lease Liability Undiscounted Excess Amount

LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

39843000

usd

CY2024Q1

ste

Operatingleaselongandshorttermliabilitycombined

177067000

usd

CY2024Q1

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P9Y10M24D

CY2023Q1

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P10Y7M6D

CY2024Q1

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.044

CY2023Q1

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.038

CY2024

ste

Amortizationandimpairmentofacquiredintangibleassets

266420000

usd

CY2023

ste

Amortizationandimpairmentofacquiredintangibleassets

256355000

usd

CY2022

ste

Amortizationandimpairmentofacquiredintangibleassets

262344000

usd

CY2024

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

25526000

usd

CY2023

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

23486000

usd

CY2022

us-gaap

Business Combination Acquisition Related Costs

BusinessCombinationAcquisitionRelatedCosts

201905000

usd

CY2024

ste

Redomiciliationcosts

620000

usd

CY2023

ste

Redomiciliationcosts

661000

usd

CY2022

ste

Redomiciliationcosts

301000

usd

CY2023

ste

Lossgainonfairvaluecontingentconsiderationadjustments

-3100000

usd

CY2022

ste

Lossgainonfairvaluecontingentconsiderationadjustments

-2350000

usd

CY2024

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

-873000

usd

CY2023

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

67000

usd

CY2022

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

874000

usd

CY2024

ste

Amortizationofinventoryandpropertystepuptofairvalue

10032000

usd

CY2023

ste

Amortizationofinventoryandpropertystepuptofairvalue

11370000

usd

CY2022

ste

Amortizationofinventoryandpropertystepuptofairvalue

53139000

usd

CY2024

us-gaap

Restructuring Charges

RestructuringCharges

44365000

usd

CY2023

us-gaap

Restructuring Charges

RestructuringCharges

485000

usd

CY2022

us-gaap

Restructuring Charges

RestructuringCharges

48000

usd

CY2024

us-gaap

Operating Income Loss

OperatingIncomeLoss

836118000

usd

CY2023

us-gaap

Operating Income Loss

OperatingIncomeLoss

791101000

usd

CY2022

us-gaap

Operating Income Loss

OperatingIncomeLoss

477815000

usd

CY2024Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1765180000

usd

CY2023Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

1632775000

usd

CY2024

us-gaap

Revenues

5138701000

usd

CY2023

us-gaap

Revenues

4536266000

usd

CY2022

us-gaap

Revenues

4223403000

usd

CY2024

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

98787000

shares

CY2023

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

99706000

shares

CY2022

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

97535000

shares

CY2024

us-gaap

Weighted Average Number Diluted Shares Outstanding Adjustment

WeightedAverageNumberDilutedSharesOutstandingAdjustment

572000

shares

CY2023

us-gaap

Weighted Average Number Diluted Shares Outstanding Adjustment

WeightedAverageNumberDilutedSharesOutstandingAdjustment

540000

shares

CY2022

us-gaap

Weighted Average Number Diluted Shares Outstanding Adjustment

WeightedAverageNumberDilutedSharesOutstandingAdjustment

791000

shares

CY2024

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

99359000

shares

CY2023

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

100246000

shares

CY2022

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

98326000

shares

CY2024Q1

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

50000000

shares

CY2024Q1

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.001

CY2024Q1

ste

Deferred Ordinary Shares

DeferredOrdinaryShares

25000

shares

CY2023Q2

us-gaap

Stock Repurchase Program Authorized Amount1

StockRepurchaseProgramAuthorizedAmount1

500000000

usd

CY2024Q1

us-gaap

Stock Repurchase Program Authorized Amount1

StockRepurchaseProgramAuthorizedAmount1

500000000

usd

CY2023

us-gaap

Stock Repurchased During Period Shares

StockRepurchasedDuringPeriodShares

1563983

shares

CY2023

ste

Ordinary Stock Repurchases Not Including Shares Withheldfor Taxes

OrdinaryStockRepurchasesNotIncludingSharesWithheldforTaxes

295000000

usd

CY2022

us-gaap

Stock Repurchased During Period Shares

StockRepurchasedDuringPeriodShares

108368

shares

CY2022

ste

Ordinary Stock Repurchases Not Including Shares Withheldfor Taxes

OrdinaryStockRepurchasesNotIncludingSharesWithheldforTaxes

25000000

usd

CY2024

us-gaap

Shares Paid For Tax Withholding For Share Based Compensation

SharesPaidForTaxWithholdingForShareBasedCompensation

76645

shares

CY2024

us-gaap

Payments Related To Tax Withholding For Share Based Compensation

PaymentsRelatedToTaxWithholdingForShareBasedCompensation

11765000

usd

CY2023

us-gaap

Shares Paid For Tax Withholding For Share Based Compensation

SharesPaidForTaxWithholdingForShareBasedCompensation

79169

shares

CY2023

us-gaap

Payments Related To Tax Withholding For Share Based Compensation

PaymentsRelatedToTaxWithholdingForShareBasedCompensation

13534000

usd

CY2022

us-gaap

Shares Paid For Tax Withholding For Share Based Compensation

SharesPaidForTaxWithholdingForShareBasedCompensation

244395

shares

CY2022

us-gaap

Payments Related To Tax Withholding For Share Based Compensation

PaymentsRelatedToTaxWithholdingForShareBasedCompensation

30775000

usd

CY2024Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

2370422

shares

CY2024

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

0.0359

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

0.0244

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

0.0110

CY2024

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

P6Y

CY2023

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

P5Y10M24D

CY2022

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

P5Y10M24D

CY2024

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

0.0108

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

0.0080

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

0.0095

CY2024

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate

0.2792

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate

0.2449

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate

0.2427

CY2024

ste

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate

0.0222

CY2023

ste

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate

0.0254

CY2022

ste

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate

0.0285

CY2023Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

1749729

shares

CY2023Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

154.60

CY2024

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod

253946

shares

CY2024

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

220.24

CY2024

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

126393

shares

CY2024

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

81.27

CY2024

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

7411

shares

CY2024

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

217.73

CY2024Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

1869871

shares

CY2024Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

168.22

CY2024

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

P6Y

CY2024Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

111633000

usd

CY2024Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

1270907

shares

CY2024Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

142.42

CY2024

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

P4Y10M24D

CY2024Q1

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

106246000

usd

CY2024Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

590113

shares

CY2024Q1

ste

Common Stock Fair Market Value Per Share

CommonStockFairMarketValuePerShare

224.82

CY2024

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

18177000

usd

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

6502000

usd

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

52952000

usd

CY2024

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

10472000

usd

CY2023

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

1828000

usd

CY2022

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

10071000

usd

CY2024

us-gaap

Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options

EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions

5470000

usd

CY2023

us-gaap

Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options

EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions

4945000

usd

CY2022

us-gaap

Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options

EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions

18143000

usd

CY2024

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

54.60

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

50.72

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

37.52

CY2023Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

28542

shares

CY2024

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

18476

shares

CY2024

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

17041

shares

CY2024

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

1629

shares

CY2024Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

28348

shares

CY2024Q1

us-gaap

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized

EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

60130000

usd

CY2024

us-gaap

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1

EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

P1Y8M12D

CY2023Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

13394000

usd

CY2022Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

13892000

usd

CY2021Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

9406000

usd

CY2024

us-gaap

Standard Product Warranty Accrual Additions From Business Acquisition

StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition

0

usd

CY2023

us-gaap

Standard Product Warranty Accrual Additions From Business Acquisition

StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition

0

usd

CY2022

us-gaap

Standard Product Warranty Accrual Additions From Business Acquisition

StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition

4553000

usd

CY2024

us-gaap

Product Warranty Accrual Warranties Issued

ProductWarrantyAccrualWarrantiesIssued

18051000

usd

CY2023

us-gaap

Product Warranty Accrual Warranties Issued

ProductWarrantyAccrualWarrantiesIssued

13195000

usd

CY2022

us-gaap

Product Warranty Accrual Warranties Issued

ProductWarrantyAccrualWarrantiesIssued

12571000

usd

CY2024

us-gaap

Standard Product Warranty Accrual Payments

StandardProductWarrantyAccrualPayments

16057000

usd

CY2023

us-gaap

Standard Product Warranty Accrual Payments

StandardProductWarrantyAccrualPayments

13693000

usd

CY2022

us-gaap

Standard Product Warranty Accrual Payments

StandardProductWarrantyAccrualPayments

12638000

usd

CY2024Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

15388000

usd

CY2023Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

13394000

usd

CY2022Q1

us-gaap

Product Warranty Accrual

ProductWarrantyAccrual

13892000

usd

CY2024

us-gaap

Equity Securities Fv Ni Gain Loss

EquitySecuritiesFvNiGainLoss

1060000

usd

CY2023

us-gaap

Equity Securities Fv Ni Gain Loss

EquitySecuritiesFvNiGainLoss

-1176000

usd

CY2022Q1

us-gaap

Business Combination Contingent Consideration Liability

BusinessCombinationContingentConsiderationLiability

10550000

usd

CY2023Q1

us-gaap

Business Combination Contingent Consideration Liability

BusinessCombinationContingentConsiderationLiability

15678000

usd

CY2024Q1

us-gaap

Business Combination Contingent Consideration Liability

BusinessCombinationContingentConsiderationLiability

11000000

usd

CY2023Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-320710000

usd

CY2022Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-209808000

usd

CY2021Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-61243000

usd

CY2024

us-gaap

Other Comprehensive Income Loss Before Reclassifications Before Tax

OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax

-6596000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Before Reclassifications Before Tax

OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax

-110437000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Before Reclassifications Before Tax

OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax

-144212000

usd

CY2024

us-gaap

Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax

ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax

1351000

usd

CY2023

us-gaap

Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax

ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax

465000

usd

CY2022

us-gaap

Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax

ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax

4353000

usd

CY2024

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-7947000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-110902000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-148565000

usd

CY2024Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-328657000

usd

CY2023Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-320710000

usd

CY2022Q1

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-209808000

usd

CY2024

us-gaap

Revenues

5138701000

usd

CY2024Q1

us-gaap

Revenues

1419387000

usd

CY2023Q4

us-gaap

Revenues

1297724000

usd

CY2023Q3

us-gaap

Revenues

1238204000

usd

CY2023Q2

us-gaap

Revenues

1183386000

usd

CY2024

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

2920541000

usd

CY2024Q1

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

836485000

usd

CY2023Q4

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

737698000

usd

CY2023Q3

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

691976000

usd

CY2023Q2

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

654382000

usd

CY2024

us-gaap

Gross Profit

GrossProfit

2218160000

usd

CY2024Q1

us-gaap

Gross Profit

GrossProfit

582902000

usd

CY2023Q4

us-gaap

Gross Profit

GrossProfit

560026000

usd

CY2023Q3

us-gaap

Gross Profit

GrossProfit

546228000

usd

CY2023Q2

us-gaap

Gross Profit

GrossProfit

529004000

usd

CY2024

ste

Gross Profit Percentage

GrossProfitPercentage

0.432

CY2024Q1

ste

Gross Profit Percentage

GrossProfitPercentage

0.411

CY2023Q4

ste

Gross Profit Percentage

GrossProfitPercentage

0.432

CY2023Q3

ste

Gross Profit Percentage

GrossProfitPercentage

0.441

CY2023Q2

ste

Gross Profit Percentage

GrossProfitPercentage

0.447

CY2024

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

702810000

usd

CY2024Q1

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

190575000

usd

CY2023Q4

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

189602000

usd

CY2023Q3

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

155852000

usd

CY2023Q2

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

166781000

usd

CY2024

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

149530000

usd

CY2024Q1

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

37276000

usd

CY2023Q4

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

40999000

usd

CY2023Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

35055000

usd

CY2023Q2

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

36200000

usd

CY2024

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

553280000

usd

CY2024Q1

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

153299000

usd

CY2023Q4

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

148603000

usd

CY2023Q3

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

120797000

usd

CY2023Q2

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

130581000

usd

CY2024

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-173201000

usd

CY2024Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-154301000

usd

CY2023Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-7658000

usd

CY2023Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-4451000

usd

CY2023Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-6791000

usd

CY2024

us-gaap

Profit Loss

ProfitLoss

380079000

usd

CY2024Q1

us-gaap

Profit Loss

ProfitLoss

-1002000

usd

CY2023Q4

us-gaap

Profit Loss

ProfitLoss

140945000

usd

CY2023Q3

us-gaap

Profit Loss

ProfitLoss

116346000

usd

CY2023Q2

us-gaap

Profit Loss

ProfitLoss

123790000

usd

CY2024

us-gaap

Net Income Loss

NetIncomeLoss

378239000

usd

CY2024Q1

us-gaap

Net Income Loss

NetIncomeLoss

-1377000

usd

CY2023Q4

us-gaap

Net Income Loss

NetIncomeLoss

140743000

usd

CY2023Q3

us-gaap

Net Income Loss

NetIncomeLoss

115319000

usd

CY2023Q2

us-gaap

Net Income Loss

NetIncomeLoss

123554000

usd

CY2024

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

5.58

CY2024Q1

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

1.55

CY2023Q4

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

1.50

CY2023Q3

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

1.21

CY2023Q2

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

1.32

CY2024

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-1.75

CY2024Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-1.56

CY2023Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-0.08

CY2023Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-0.04

CY2023Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-0.07

CY2024

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

3.83

CY2024Q1

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-0.01

CY2023Q4

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.42

CY2023Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.17

CY2023Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.25

CY2024

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

5.55

CY2024Q1

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

1.54

CY2023Q4

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

1.49

CY2023Q3

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

1.20

CY2023Q2

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

1.31

CY2024

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-1.74

CY2024Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-1.55

CY2023Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-0.08

CY2023Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-0.04

CY2023Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-0.07

CY2024

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

3.81

CY2024Q1

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-0.01

CY2023Q4

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.42

CY2023Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.16

CY2023Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.25

CY2023

us-gaap

Revenues

4536266000

usd

CY2023Q1

us-gaap

Revenues

1281252000

usd

CY2022Q4

us-gaap

Revenues

1112431000

usd

CY2022Q3

us-gaap

Revenues

1090939000

usd

CY2022Q2

us-gaap

Revenues

1051644000

usd

CY2023

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

2555540000

usd

CY2023Q1

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

734850000

usd

CY2022Q4

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

634244000

usd

CY2022Q3

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

608627000

usd

CY2022Q2

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

577819000

usd

CY2023

us-gaap

Gross Profit

GrossProfit

1980726000

usd

CY2023Q1

us-gaap

Gross Profit

GrossProfit

546402000

usd

CY2022Q4

us-gaap

Gross Profit

GrossProfit

478187000

usd

CY2022Q3

us-gaap

Gross Profit

GrossProfit

482312000

usd

CY2022Q2

us-gaap

Gross Profit

GrossProfit

473825000

usd

CY2023

ste

Gross Profit Percentage

GrossProfitPercentage

0.437

CY2023Q1

ste

Gross Profit Percentage

GrossProfitPercentage

0.426

CY2022Q4

ste

Gross Profit Percentage

GrossProfitPercentage

0.430

CY2022Q3

ste

Gross Profit Percentage

GrossProfitPercentage

0.442

CY2022Q2

ste

Gross Profit Percentage

GrossProfitPercentage

0.451

CY2023

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

680266000

usd

CY2023Q1

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

203402000

usd

CY2022Q4

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

171539000

usd

CY2022Q3

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

159325000

usd

CY2022Q2

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

146000000

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

124069000

usd

CY2023Q1

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

21203000

usd

CY2022Q4

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

40534000

usd

CY2022Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

35417000

usd

CY2022Q2

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

26915000

usd

CY2023

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

556197000

usd

CY2023Q1

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

182199000

usd

CY2022Q4

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

131005000

usd

CY2022Q3

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

123908000

usd

CY2022Q2

us-gaap

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

119085000

usd

CY2023

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-450384000

usd

CY2023Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

4765000

usd

CY2022Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-7680000

usd

CY2022Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-439139000

usd

CY2022Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity

IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

-8330000

usd

CY2023

us-gaap

Profit Loss

ProfitLoss

105813000

usd

CY2023Q1

us-gaap

Profit Loss

ProfitLoss

186964000

usd

CY2022Q4

us-gaap

Profit Loss

ProfitLoss

123325000

usd

CY2022Q3

us-gaap

Profit Loss

ProfitLoss

-315231000

usd

CY2022Q2

us-gaap

Profit Loss

ProfitLoss

110755000

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

107030000

usd

CY2023Q1

us-gaap

Net Income Loss

NetIncomeLoss

187225000

usd

CY2022Q4

us-gaap

Net Income Loss

NetIncomeLoss

123828000

usd

CY2022Q3

us-gaap

Net Income Loss

NetIncomeLoss

-315285000

usd

CY2022Q2

us-gaap

Net Income Loss

NetIncomeLoss

111262000

usd

CY2023

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

5.59

CY2023Q1

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

1.84

CY2022Q4

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

1.32

CY2022Q3

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

1.24

CY2022Q2

us-gaap

Income Loss From Continuing Operations Per Basic Share

IncomeLossFromContinuingOperationsPerBasicShare

1.19

CY2023

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-4.52

CY2023Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

0.05

CY2022Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-0.08

CY2022Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-4.39

CY2022Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Basic Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

-0.08

CY2023

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.07

CY2023Q1

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.89

CY2022Q4

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.24

CY2022Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-3.15

CY2022Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.11

CY2023

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

5.56

CY2023Q1

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

1.83

CY2022Q4

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

1.31

CY2022Q3

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

1.24

CY2022Q2

us-gaap

Income Loss From Continuing Operations Per Diluted Share

IncomeLossFromContinuingOperationsPerDilutedShare

1.19

CY2023

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-4.49

CY2023Q1

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

0.05

CY2022Q4

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-0.08

CY2022Q3

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-4.39

CY2022Q2

us-gaap

Income Loss From Discontinued Operations Net Of Tax Per Diluted Share

IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

-0.08

CY2023

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.07

CY2023Q1

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.88

CY2022Q4

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.24

CY2022Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-3.15

CY2022Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.10

CY2024

ecd

Non Rule10b51 Arr Adopted Flag

NonRule10b51ArrAdoptedFlag

false

CY2024

ecd

Rule10b51 Arr Adopted Flag

Rule10b51ArrAdoptedFlag

false

CY2024

ecd

Rule10b51 Arr Trmntd Flag

Rule10b51ArrTrmntdFlag

false

CY2024

ecd

Non Rule10b51 Arr Trmntd Flag

NonRule10b51ArrTrmntdFlag

false

Name	View Source	Status
0001757898-24-000008-index-headers.html	Edgar Link	pending
0001757898-24-000008-index.html	Edgar Link	pending
0001757898-24-000008.txt	Edgar Link	pending
0001757898-24-000008-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ste-20240331.htm	Edgar Link	pending
ste-20240331.xsd	Edgar Link	pending
ste03312024ex191.htm	Edgar Link	pending
ste03312024ex191001.jpg	Edgar Link	pending
ste03312024ex191002.jpg	Edgar Link	pending
ste03312024ex191003.jpg	Edgar Link	pending
ste03312024ex191004.jpg	Edgar Link	pending
ste-20240331_pre.xml	Edgar Link	unprocessable
ste-20240331_lab.xml	Edgar Link	unprocessable
ste-20240331_htm.xml	Edgar Link	completed
ste03312024ex191005.jpg	Edgar Link	pending
ste03312024ex191006.jpg	Edgar Link	pending
ste03312024ex191007.jpg	Edgar Link	pending
ste03312024ex191008.jpg	Edgar Link	pending
ste03312024ex191009.jpg	Edgar Link	pending
ste03312024ex191010.jpg	Edgar Link	pending
ste03312024ex191011.jpg	Edgar Link	pending
ste03312024ex191012.jpg	Edgar Link	pending
ste03312024ex191013.jpg	Edgar Link	pending
ste03312024ex191014.jpg	Edgar Link	pending
ste03312024ex191015.jpg	Edgar Link	pending
ste03312024ex191016.jpg	Edgar Link	pending
ste03312024ex191017.jpg	Edgar Link	pending
ste03312024ex191018.jpg	Edgar Link	pending
ste03312024ex2111.htm	Edgar Link	pending
ste03312024ex2311.htm	Edgar Link	pending
ste03312024ex2411.htm	Edgar Link	pending
ste03312024ex3111.htm	Edgar Link	pending
ste03312024ex3121.htm	Edgar Link	pending
ste03312024ex3211.htm	Edgar Link	pending
ste03312024ex971.htm	Edgar Link	pending
ste-20240331_def.xml	Edgar Link	unprocessable
ste-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STE
STERIS plc Stock $ste

2024 Q2 Form 10-K Financial Statement

#000175789824000008 Filed on May 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STE STERIS plc Stock $ste

2024 Q2 Form 10-K Financial Statement

#000175789824000008 Filed on May 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STE
STERIS plc Stock $ste